Skip to contents
NHLBI Women's Health Initiative
Women's Health Initiative banner
 

WHI HOME

CONTACT

BROAD AGENCY ANNOUNCEMENT

WHI PARTICIPANT WEBSITE

WHI SCIENTIFIC RESOURCES WEBSITE

PRESS RELEASES

PUBLICATIONS

LEGACY CONFERENCE

WHI PARTICIPANT UPDATES

NHLBI POSTMENOPAUSAL HORMONE THERAPY

Estrogen-Alone Study

Estrogen-Plus-Progestin Study

DIETARY MODIFICATION TRIAL

CALCIUM and VITAMIN D TRIAL

OBSERVATIONAL STUDY

Q & As for WHI STUDY PARTICIPANTS

WHI Background and Overview

WHI Update

Why WHI?

WHI Community Prevention Study

Additional Resources
   

WHI PUBLICATIONS

Updated 5/12/11


  • Behavioral, Quality of Life, and Lifestyle

  • Calcium and Vitamin D/Bone

  • Cancer

  • Cardiovascular

  • Cognition and Dementia

  • Design and Methods

  • Diet

  • Hormone Therapy

  • Other

  • Pelvic Prolapse and Urinary Incontinence

    Behavioral, Quality of Life, and Lifestyle

    1. Brennan RM, Wactawski-Wende J, Crespo CJ, Dmochowski J. “Factors Associated with Treatment Initiated after Osteoporosis Screening." Am J Epidemiol 2004;160:475-483.
    2. Bush RA, Langer RD. “The Effects of Insurance Coverage and Ethnicity on Mammography Utilization in a Postmenopausal Population." West J Med 1998;Apr;168(4):236-240.
    3. Evenson KR, Wilcox S, Pettinger M, Brunner R, King AC, McTiernan A. “Vigorous Leisure Activity through Women's Adult Life: The Women's Health Initiative Observational Cohort Study." Am J Epidemiology 2002;156:945-953.
    4. Gold R, Michael YL, Whitlock EP, Hubbell FA, Mason ED, Rodriguez BL, Safford MM, Sarto GE. “Race/Ethnicity, Socioeconomic Status, and Lifetime Morbidity Burden in the Women's Health Initiative." Journal of Women's Health 2006;15(10):1161-1173.
    5. Holahan CK, Holahan CJ, Powers DA, Hayes RB, Marti CN, and Ockene JK. “Depressive Symptoms and Smoking in Middle-Aged and Older Women.” Nicotine Tob Res. 2011 Apr 19. [Epub ahead of print].
    6. Hopkins, Burrows B, Bowen D, Tinker l. “Labeling as a Predictor of Dietary Maintenance." J Nutr Edu 2001;33:278-283.
    7. Hsia J, Kemper E, Sofaer S, Bowen D, Kiefe C, Zapka J, Mason E, Lillington L, Limacher L. “Is Insurance a More Important Determinant of Healthcare Access Than Perceived Health? Evidence from the Women's Health Initiative." Journal of Women's Health; Gender-Based Medicine 2000;9(8):881-889.
    8. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, Bowen D, Limacher M, Lillington L, Mason E. “The Importance of Health Insurance as a Determinant of Cancer Screening: Evidence from the Women's Health Initiative." Preventive Medicine 2000;31:261-270.
    9. Hsia J. Wu L, Allen C, Oberman A, Lawson WE, Torrens J, Safford M, Limacher MC, Howard BV. “Physical Activity and Diabetes Risk in Postmenopausal Women." Am J Prev Med 2005;28(1):19-25.
    10. Kearney MH, Rosal MC, Ockene JK, Churchill LC. “Influences on Older Women's Adherence to a Low-Fat Diet in the Women's Health Initiative." Psychosom Med 2002;64(3):450-457.
    11. Kripke DF, Brunner R, Freeman R, Hendrix S, Jackson RD, Masaki K, Carter RA. “Sleep Complaints of Postmenopausal Women." Clinical Journal of Women's Health 2001;1:244-252.
    12. McTiernan A, Kooperberg C, White E, Wilcox S, Adams-Campbell LL, Woods N, Ockene J. “Recreational Physical Activity and the Risk of Breast Cancer in Postmenopausal Women: The Women's Health Initiative Cohort Study." JAMA 2003;290:1331-1336.
    13. Messina CR, Lane DS, Glanz K, West DS, Taylor V, Frishman W, Powell L. “Relationship of Social Support and Social Burden to Repeated Breast Cancer Screening in the Women's Health Initiative." Health Psychology 2004;23(6):582-594.
    14. Mossavar-Rahmani Y, Garland CF, Caan B, Hebert JR, Wodarski LA, Vitolins MZ, Himes JH, Parker LM. “Yogurt Consumption is Associated with Healthy Behavior in Postmenopausal Women." Clinical Journal of Women's Health 2002;2(3):128-134.
    15. Salmoirago-Blotcher E, Fitchett G, Ockene JK, Schnall E, Crawford S, Granek I, Manson J, Ockene I, O'Sullivan MJ, Powell L, Rapp S. ”Religion and Healthy Lifestyle Behaviors Among Postmenopausal Women: the Women's Health Initiative.” J Behav Med. 2011 Feb 8. [Epub ahead of print].
    16. Shikany JM. “Fat Intake in Husbands of Participants in the Dietary Modification Component of the Women's Health Initiative." Nutr Res 2002;22:577-586.
    17. Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, Dicken T, Oberman A, Sheps DS. “Prevalence and Correlates of Panic Attacks in Postmenopausal Women." Arch Intern Med 2003;163:2041-2050.
    18. Tinker LF, Perri MG, Patterson RE, Bowen DJ, McIntosh M, Parker LM, Sevick MA, Wodarski LA. “The Effects of Physical and Emotional Status on Adherence to a Low-Fat Dietary Pattern in the Women's Health Initiative." J Am Diet Assoc 2002;102:789-800.
    19. Wilcox S, Everson KR, Aragaki A, Wassertheil-Smoller S, Mouton CP, Loevinger BL. “The Effects of Widowhood on Physical and Mental Health, Health Behaviors, and Health Outcomes: The Women's Health Initiative." Health Psychology 2003;22(5):513-522.
    20. Yost KJ, Haan MN, Levine RA, Gold EB. “Comparing SF-36 Scores Across Three Groups of Women with Different Health Profiles." Quality of Life Research 2005;14:1251-1261.

    Calcium and Vitamin D/Bone

    1. Barondess DA, Singh M, Hendrix SL, Nelson DA. “Radiographic Measurements, Bone Mineral Density and the Singh Index in the Proximal Femur of White and Black Postmenopausal Women." Clin J Women's Health 2001;1(5):253-258.
    2. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL. “Risk of Fracture in Women with Type 2 Diabetes: The Women's Health Initiative Observational Study." J Clin Endocrinol Metab 2006;91(9):3404-3410.
    3. Brennan RM, Genco RJ, Hovey KM, Trevisan M, Wactawski-Wende J. “Clinical Attachment Loss, Systemic Bone Density, and Subgingival Calculus in Postmenopausal Women.” J Periodontal Nov 2007;78(11):2104-2111.
    4. Brennan-Calanan RM, Genco RJ, Wilding GE, Hovey KM, Trevisan M, Wactawski-Wende J. “Osteoporosis and Oral Infection: Independent Risk Factors for Oral Bone Loss.” J Dent Res 2008;87(4):323-327.
    5. Brunner RL, Cochrane B, Jackson RD, Larson J, Lewis C, Limacher M, Rosal M, Shumaker S, Wallace R; Women’s Health Initiative Investigators. “Calcium, Vitamin D Supplementation, and Physical Function in the Women’s Health Initiative.” J Am Diet Assoc Sep 2008;108(9):1472-1479.
    6. Brunner R, Dunbar-Jacob J, Leboff MS, Granek I, Bowen D, Snetselaar LG, Shumaker SA, Ockene J, Rosal M, Wactawski-Wende J, Cauley J, Cochrane B, Tinker L, Jackson R, Wang CY, Wu L. “Predictors of Adherence in the Women's Health Initiative Calcium and Vitamin D Trial.” Behav Med 2009 Jan 1;34(4):145-155.
    7. Caan B, Neuhouser M, Aragaki A, Lewis CB, Jackson R, LeBoff MS, Margolis KL, Powell L, Uwaifo G, Whitlock E, Wylie-Rosett J, LaCroix A. “Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain." Arch Intern Med 2007;167:893-902.
    8. Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z. “Vitamin A and Retinol Intakes and the Risk of Fractures among Participants of the Women's Health Initiative Observational Study." Am J Clin Nutr 2008 Dec 3. [Epub ahead of print].
    9. Carbone LD, Johnson KC, Bush AJ, Robbins J, Larson JC, Thomas A, LaCroix AZ. "Loop Diuretic Use and Fracture in Postmenopausal Women: Finds from the Women's Health Initiative." Arch Intern Med 2009;169(2):132-140.
    10. Cauley JA, Wampler NS, Barnhart JM, Wu L, Allison M, Chen Z, Hendrix S, Robbins J, Jackson RD. “Incidence of Fractures Compared to Cardiovascular Disease and Breast Cancer; The Women’s Health Initiative Observational Study.” Osteoporos Int 2008;19:1717-1723.
    11. Cauley JA, LaCroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, Lee JS, Jackson RD, Robbins JA, Wu C, Stanczyk FZ, LeBoff MS, Wactawski-Wende J, Sarto G, Ockene J, Cummings SR. “Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures.” Ann Intern Med Aug 2008;149(4):242-250.
    12. Cauley JA, Wu L, Wampler NS, Barnhart JM, Allison M, Chen Z, Jackson R, Robbins J. “Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative.” J Bone Miner Res 2007 Nov;22(11):1816-26.
    13. Chen Z, Pettinger MB, Ritenbaugh C, LaCroix AZ, Robbins J, Caan BJ, Barad DH, Hakim IA. “Habitual Tea Consumption and Risk of Osteoporosis: A Prospective Study in the Women's Health Initiative Observational Cohort." Am J Epidemiol 2003;158:772-781.
    14. Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, Bass M, LeBoff MS. “Fracture Risk Among Breast Cancer Survivors: Results from the Women's Health Initiative Observational Study." Arch Intern Med 2005;165:552-558.
    15. Chen Z, Maricic M, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, Gass M, LeBoff MS, Bassford TL. “Osteoporosis and Rate of Bone Loss among Postmenopausal Survivors of Breast Cancer." Cancer 2005;104:1520-1530.
    16. Chen Z, Wang Z, Lohman T, Heymsfield SB, Outwater E, Nicholas JS, Bassford T, LaCroix A, Sherrill D, Punyanitya M, Wu G, Going S. “Dual-Energy X-Ray Absorptiometry is a Valid Tool for Assessing Skeletal Muscle Mass in Older Women.” J Nutr 2007 Dec;137(12):2775-80.
    17. Chen Z, Arendell L, Aichkin M, Cauley J, Lewis CE, Chlebowski R. “Hip Bone Density Predicts Breast Cancer Risk independently of Gail Score: Results from the Women’s Health Initiative.” Cancer Sep 2008;113(5):901-915.
    18. Chen Z, Thomson CA, Aickin M, Nicholas JS, Van Wyck D, Lewis CE, Cauley JA, Bassford T; Short list of Women's Health Initiative Investigators. “The Relationship between Incidence of Fractures and Anemia in Older Multiethnic Women." J Am Geriatr Soc. 2010 Dec;58(12):2337-2344.
    19. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA; for the Women's Health Initiative Investigators. “Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer.” J Natl Cancer Inst 2008 Nov 19;100(22):1581-1591.
    20. Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, Rohan T, O’Sullivan MJ, Yasmeen S, Hiatti RA, Shikany JM, Vitolins M, Khandekar J, and Hubbell FA. “25-Hydroxyvitamin D Concentration, Vitamin D Intake and Joint Symptoms in Postmenopausal Women." Maturitas. 18 Nov 2010. [Epub ahead of print].
    21. de Boer IH, Kestenbaum B, Siscovick DS, Weiss NS, Tinker LF, Connelly S, Curb JD, Howard BV, Larson JC, Manson JE, Margolis KL. “Calcium Plus Vitamin D Supplementation and the Risk of Incident diabetes Mellitus in the Women's Health Initiative." Diabetes Care 2008 Jan 30 Epub.
    22. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, for the Women's Health Initiative Investigators. “Calcium/Vitamin D Supplementation and Cardiovascular Events." Circulation 2007;115:846-854.
    23. Jackson R, LaCroix A, Cauley J, McGowan J. “The WHI CaD Trial: Overview and Baseline Characteristics of Participants." Ann Epidemiol 2003;13:S98-S106.
    24. Jackson RD, LaCroix AZ, Gass M, et al. “The Women's Health Initiative Trial of Calcium plus Vitamin D Supplementation on Risk for Fractures." NEJM 2006;354:669-683.
    25. Jackson RD, Shidham S. “The Role of Hormone Therapy and Calcium plus Vitamin D for Reduction of Bone Loss and Risk For Fractures: Lessons Learned from the Women's Health Initiative.” Curr Osteoporos Rep 2007 Dec;5(4):153-9.
    26. Jackson RD, Donepudi S, Mysiw WJ. “Epidemiology of Fracture Risk in the Women’s Health Initiative.” Curr Osteoporos Rep 2008 Dec;6(4):155-61.
    27. Jackson RD, Wright NC, Beck TJ, Sherrill D, Cauley JA, Lewis CE, Lacroix AZ, Leboff MS, Going S, Bassford T, Chen Z. ”Calcium Plus Vitamin D Supplementation Has Limited Effects On Femoral Geometric Strength in Older Postmenopausal Women: The Women's Health Initiative.” Calcif Tissue Int. 2011 Jan 21. [Epub ahead of print].
    28. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, Sarto GE, Robbins J, Phillips L, Martin LW, O’Sullivan MJ, Jackson R, Rodabough RJ, and Stefanick ML. “Oophorectomy vs Ovarian Conservation with Hysterectomy: Cardiovascular Disease, Hip Fracture, and Cancer in the Women’s Health Initiative Observational Study.” Arch Intern Med. 2011;171(8):760-768.
    29. Jeffcoat MK, Lewis CE, Reddy MS, Wang CY, Redford M. “Post-Menopausal Bone Loss and It's Relationship to Oral Bone Loss." Periodontol 2000 2001;23(1):94-102.
    30. LaCroix AZ, Cauley JA, Pettinger M, Hsia J, Bauer DC, McGowan J, Chen Z, Lewis CE, McNeeley SG, Passaro MD, Jackson RD. “Statin Use, Clinical Fracture, and Bone Density in Postmenopausal Women: Results from the Women's Health Initiative Observational Study." Ann Internal Med 2003;139:97-104.
    31. LaCroix AZ, Lee JS, Wu L, Cauley JA, Shlipak MG, Ott SM, Robbins J, Curb JD, LeBoff M, Bauer DC, Jackson RD, Kooperberg CL, Cummings SR. “Cystatin-C, Renal Function, and Incidence of Hip Fracture in Postmenopausal Women.” J Am Geriatr Soc 2008 Jul 24. [Epub ahead of print]
    32. LaCroix AZ, Kotchen J, Anderson G, Brazyski R, Cauley JA, Cummings SR, Gass M, Johnson KC, Ko M, Larson J, Manson JE, Stefanick ML, Wactawski J. “Calcium plus Vitamin D Supplementation and Mortality in Postmenopausal Women: The Women's Health Initiative Calcium-Vitamin D Randomized Controlled Trial." J Gerontol, Medical Sciences 2009 Feb 16. [Epub ahead of print].
    33. LaCroix AZ, Beck TJ, Cauley JA, Lewis CE, Bassford T, Jackson R, Wu G, Chen Z. “Hip Structural Geometry and Incidence of Hip Fracture in Postmenopausal Women: What Does It Add to Conventional Bone Mineral Density?"Osteoporos Int. 2009 Sep 15. [Epub ahead of print]
    34. LeBoff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, Bauer DC, Cauley J, Kooperberg C, Lewis C, Thomas AM, Cummings S. "Homocysteine Levels and Risk of Hip Fracture in Postmenopausal Women." J Clin endocrinol Metab 2009 Jan 27. [Epub ahead of print].
    35. Lee JS, LaCroix AZ, Wu L, Cauley JA, Jackson RD, Kooperberg C, LeBoff MS, Robbins J, Lewis CE, Bauer DC, Cummings SR. “Associations of Serum Sex Hormone-Binding Globulin and Sex Hormone Concentrations with Hip Fracture Risk in Postmenopausal Women.” J Clin Endocrinal Metab May 2008;93(5):1796-1803.
    36. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, Beresford SAA, Connelly SA, Curb JD, Grimm RH, Kotchen TA, Kuller LH, Wassertheil-Smoller S, Thomson CA, Torner JC, for the Women’s Health Initiative Investigators. “Effect of Calcium and Vitamin D Supplementation on Blood Pressure. The Women’s Health Initiative Randomized Trial.” Hypertension Nov 2008;52:847-855.
    37. McLeod, KM, McCann SE, Horvath PJ, Wactawski-Wende J. “Predictors of Change in Calcium Intake in Postmenopausal Women after Osteoporosis Screening." J Nutr 2007 Aug;137(8):1968-1973.
    38. Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, Hageman GS, Chappell R, Blodi BA, Klein ML, Gehrs KM, Sarto GE, and Mares JA; for the CAREDS Study Group. “Vitamin D Status and Early Age-Related Macular Degeneration in Postmenopausal Women.” Arch Ophthalmol. 2011;129(4):481-489.
    39. Nelson DA, Barondess DA, Hendrix SL, Beck TJ. “Cross-Sectional Geometry, Bone Strength and Bone Mass in the Proximal Femur in African-American and White Postmenopausal Women." J Bone Miner Res 2000;15(10):1992-1997.
    40. Orchard TS, Cauley JA, Frank GC, Neuhouser ML, Robinson JG, Snetselaar L, Tylavsky F, Wactawski-Wende J, Young AM, Lu B and Jackson RD. “Fatty Acid Consumption and Risk of Fracture in the Women’s Health Initiative." Am J Clin Nutr. 2010 Oct 27. [Epub ahead of print].
    41. Robbins J, Schott AM, Azari R, Kronmal R. “Body Mass Index is not a Good Predictor of Bone Density: Results from WHI, CHS, and EPIDOS.” J Clin Densitom 2006 Jul-Sep;9(3):329-34.
    42. Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS, Ginsberg M, Wassertheil-Smoller S, Page DL. “A Randomized Controlled Trial of Calcium Plus Vitamin D Supplementation and Risk of Benign Proliferative Breast Disease.” Breast Cancer Res Treat 2008 Oct 14. [Epub ahead of print]
    43. Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J. “Factors associated with 5-Year Risk of Hip Fracture in Postmenopausal Women." JAMA 2007;298(20):2389-2398.
    44. Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM, Melville JL, LaCroix AZ. “Depressive Symptoms, Bone Loss, and Fractures in Postmenopausal Women." J Gen Intern Med 2008 Feb 20 [Epub ahead of print].
    45. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. “Calcium and Vitamin D Supplementation and Colorectal Cancer in Postmenopausal Women: The Women's Health Initiative Clinical Trial." NEJM 2006;354:684-696.
    46. Wactawski-Wende J, Hausmann E, Hovey K, Trevisan M, Grossi S, Genco RJ. “The Association between Osteoporosis and Alveolar Crestal Height in Postmenopausal Women.” J Peridontol Nov 2005;76(11 Suppl):2116-2124.
    47. Wallace RB, Wactawski-Wende J, O'Sullivan MJ, Larson JC, Cochrane B, Gass M, and Masaki K. “Urinary Tract Stone Occurrence in the Women's Health Initiative Randomized Clinical Trial of Calcium and Vitamin D Supplements.” Am J Clin Nutr. 2011 Apr 27. [Epub ahead of print].
    48. Wampler NS, Chen Z, Jacobsen C, Henderson JA, Howard BV, Rossouw JE. “Bone Mineral Density of American Indian and Alaska Native Women Compared with Non-Hispanic White Women: Results from the Women's Health Initiative Study." Menopause 2005;12(5):536-544.
    49. Wolf RL, Cauley JA, Pettinger M, Jackson R, LaCroix A, Leboff MS, Lewis CE, Nevitt MC, Simon JA, Stone KL, Wactawski-Wende J. “Lack of a Relation Between Vitamin and Mineral Antioxidants and Bone Mineral Density: Results from the Women's Health Initiative." Am J Clin Nutr 2005;82:581-588.

    Cancer

    1. Abel EL, Hendrix SL, McNeeley GS, O'Leary ES, Mossavar-Rahmani Y, Johnson SR, Kruger M. “Use of Electric Blankets and Association with Prevalence of Endometrial Cancer." European Journal of Cancer Prevention 2007;16:243-250.
    2. Abel EL, Hendrix SO, McNeeley SG, Johnson KC, Rosenberg CA, Mossavar-Rahmani Y, Vitolins M, Kruger M. “Daily Coffee Consumption and Prevalence of Nonmelanoma Skin Cancer in Caucasian Women.” Eur J Cancer Prev 2007 Oct;16(5):446-452.
    3. Aggarwal A, Freund K, Sato A, Adams-Campbell LL, Lopez AM, Lessin LS, Ockene J, Wallace RB, Williams CD, Bonds DE. “Are Depressive Symptoms Associated With Cancer Screening and Cancer Stage at Diagnosis Among Postmenopausal Women? The Women’s Health Initiative Observational Cohort.” J Women’s Health Oct 2008;17(8):1353-1361.
    4. Allison M, Garland C, Chlebowski R, Criqui M, Langer R, Wu L, Roy H, McTiernan A, Kuller L. “The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women." Am J Epidemiol 2006;164:567-575.
    5. Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL. “Hormonal Factors and Risks of Esophageal Squamous Cell Carcinoma and Adenocarcinoma in Postmenopausal Women.” Cancer Prev Res (Phila). 2011 Apr 19. [Epub ahead of print].
    6. Bós AM, Howard BV, Beresford SA, Urban N, Tinker LF, Waters H, Bós AJ, Chlebowski R, Ennis JM. “Cost-Effectiveness Analysis of a Low-Fat Diet in the Prevention of Breast and Ovarian Cancer." J Am Diet Assoc. 2011 Jan;111(1):56-66.
    7. Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT. “Statin Use and Breast Cancer: Prospective Results From the Women's Health Initiative." JNCI 2006;98(10):700-707.
    8. Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT, Women's Health Initiative Research Group. “Statin Use and Breast Cancer: Prospective Results from The Women's Health Initiative.” J Natl Cancer Inst 2006 May 17;98(10):700-7.
    9. Chlebowski RT, Pettinger M, Stefanick ML, Howard BV, Mossavar0Rahmani Y, McTiernan A. “Insulin, Physical Activity, and Caloric Intake in Postmenopausal Women: Breast Cancer Implications." JCO Nov 15 2004;4507-4513.
    10. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R. “Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome." JNCI 2005;97(6):439-448.
    11. Cui Y, Page DL, Chlebowski RT, Hsia J, Hubbell FA, Johnson KC, Rohan TE. “Cigarette Smoking and Risk of Benign Proliferative Epithelial Disorders of the Breast in the Women's Health Initiative." Cancer Causes Control 2007;18(4):431-438.
    12. Cui Y, Page DL, Chlebowski RT, Beresford SA, Hendrix SL, Lane DS, Rohan TE. “Alcohol and Folate Consumption and Risk of Benign Proliferative Epithelial Disorders of the Breast." Int J Cancer 2007;121(6):1346-1351.
    13. Cui Y, Page DL, Lane DS, Rohan TE. “Menstrual and Reproductive History, Postmenopausal Hormone Use, and Risk of Benign Proliferative Epithelial Disorders of the Breast: A Cohort Study.” Breast Cancer Res Treat 2008 Mar 22 [Epub ahead of print].
    14. Cui Y, Shikany JM, Liu S, Yasmeen S, Rohan TE. “Selected Antioxidants and Risk of Hormone Receptor-Defined Invasive Breast Cancers among Postmenopausal Women in the Women’s Health Initiative Observational Study.” Am J Clin Nutr Apr 2008;87(4):1009-1018.
    15. Duffy CM, Assaf A, Cyr M, Burkholder G, Coccio E, Rohan T, McTiernan A, Paskett E, Lane D, Chetty VK. “Alcohol and Folate Intake and Breast Cancer Risk in the WHI Observational Study.” Breast Cancer Res Treat 2008 Sep 11. [Epub ahead of print].
    16. Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS, Lee JS. ”Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers.” J Natl Cancer Inst. 2011 Feb 17. [Epub ahead of print].
    17. Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, and McCaskill-Stevens W. “Benefit/Risk Assessment for Breast Cancer Chemoprevention with Raloxifene or Tamoxifen for Women Age 50 Years or Older.” J Clin Oncol. 2011 May 2. [Epub ahead of print].
    18. Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice R, Patterson R, Carroll R, Subar AF. “A Comparison of Two Dietary Instruments for Evaluating the Fat-Breast Cancer Relationship.” Int J Epidemiol 2006 Aug;35(4):1011-21.
    19. Gail MH, Constantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L. “Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women." J Natl Cancer Inst 2007;99:1782-1792.
    20. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GY, Einstein MH, Kaplan RC, Burk RD, Wylie-Rosett J, Pollak MN, Anderson G, Howard BV, Strickler HD. “A Prospective Evaluation of Insulin and Insulin-Like Growth Factor-1 as Risk Factors for Endometrial Cancer.” Cancer Epidemiol Biomarkers Prev Apr 2008;17(4):921-929.
    21. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GYF, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD. "Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women." J Nat Cancer I 2008 Dec 30. [Epub ahead of print].
    22. Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A. “Breast Cancer and Nonsteroidal Anti-Inflammatory Drugs: Prospective Results from the Women's Health Initiative." Cancer Research 2003;63:6096-6101.
    23. Irwin ML, McTiernan A, Manson JE et al. “Physical Activity and survival in Postmenopausal Women with Breast Cancer: Results from the Women’s Health Initiative.” Cancer Prev Res 2011;4:522-529.
    24. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, Sarto GE, Robbins J, Phillips L, Martin LW, O’Sullivan MJ, Jackson R, Rodabough RJ, and Stefanick ML. “Oophorectomy vs Ovarian Conservation with Hysterectomy: Cardiovascular Disease, Hip Fracture, and Cancer in the Women’s Health Initiative Observational Study.” Arch Intern Med. 2011;171(8):760-768.
    25. Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE. “Body Mass Index and Waist Circumference in Relation to Lung Cancer Risk in the Women’s Health Initiative.” Am J Epidemiol Jul 2008;168(2): 158-169.
    26. Kocarnik JD, Hutter CM, Slattery ML, Berndt SI, Hsu L, Duggan DJ, Muehling J, Caan BJ, Beresford SA, Rajkovic A, Sarto G, Marshall JR, Hammad N, Wallace RB, Makar KW, Prentice RL, Potter JD, Hayes RB, Peters U. “Characterization of 9p24 Risk Locus and Colorectal Adenoma and Cancer: Gene-Environment Interaction and Meta-Analysis." Cancer Epidemiol Biomarkers Prev. 2010 Oct 26. [Epub ahead of print].
    27. Luo J, Margolis KL, Adami HO, Lopez AM, Lessin L, Ye W; for the Women's Health Initiative Investigators. “Body Size, Weight Cycling, and Risk of Renal Cell Carcinoma among Postmenopausal Women: The Women's Health Initiative." Am J Epidemiol 2007;166(7):752-759.
    28. Luo J, Margolis KL, Adami H-O, LaCroix A, Ye W, Women’s Health Initiative Investigators. “Obesity and Risk of Pancreatic Cancer among Postmenopausal Women: The Women’s Health Initiative (United States).” Br J Cancer Aug 2008;99(3):527-531.
    29. Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, Stefanick ML,Tindle HA, Tong E, and Rohan TE. ”Association of Active and Passive Smoking with Risk of Breast Cancer among Postmenopausal Women: A Prospective Cohort Study.” BMJ. 2011 Mar 1. [Epub ahead of print].
    30. Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A; for the Women's Health Initiative Research Group. “Prospective Study of Leukocyte Count as a Predictor of Incident Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women.” Arch Intern Med 2007 Sep 24;167(17):1837-44.
    31. Michael YL, Carlson NE, Chlebowski RT, Aickin M, Weihs KL, Ockene JK, Bowen DJ, Ritehbaugh C. “Influence of Stressors on Breast Cancer Incidence in the Women's Health Initiative." Health Psychol 2009 Mar;28(2):137-146.
    32. Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollack MN, Ma J, Fuchs CS. “Prediagnostic Plasma C-Peptide and Pancreatic Cancer Risk in Men and Women." Cancer Epidemiol Biomarkers Prev 2007;16(10):2101-2109.
    33. Millen AE, Pettinger M, Freudenheim JL, Langer RD, Rosenberg CA, Mossavar-Rahmani Y, Duffy CM, Lane DS, McTiernan A, Kuller LH, Lopez AM, Wactawski-Wende J. "Incident Invasive Breast Cancer, Geographic Location of Residence, and Reported Average Time Spent Outside." Cancer Epidemiol Biomarkers Prev 2009 Feb 3. [Epub ahead of print]
    34. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A.  “Obesity, Body Size, and Risk of Postmenopausal Breast Cancer: The Women's Health Initiative." Cancer Causes and Control 2002;13:741-751.
    35. Paskett ED, Reeves KW, Rohan TE, Allison MA, Williams CD, Messina CR, Whitlock E, Sata A, Hunt JR. “Association Between Cigarette Smoking and Colorectal Cancer in the Women's Health Initiative." J Natl Cancer Inst 2007;99:1729-1735.
    36. Paskett ED, Alfano CM, Davidson MA, Andersen BL, Naughton MJ, Sherman A, McDonald PG, Hays J. “Breast Cancer Survivors’ Health-Related quality of Life: Racial Differences and Comparisons with Noncancer Controls.” Cancer Dec 2008;113(11):3222-3230.
    37. Pitteri SJ, Amon LM, Buson TB, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong CH, Zhang Q, Wang H, Lampe PD, Prentice RL, McIntosh MW, Hanash SM, and Li CI. “Detection of Elevated Plasma Levels of Epidermal Growth Factor Receptor before Breast Cancer Diagnosis among Hormone Therapy Users." Cancer Res. 19 Oct 2010. [Epub ahead of print].
    38. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. ”Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer.” J Natl Cancer Inst. 2011 Feb 23. [Epub ahead of print].
    39. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M, Kabat GC, Rohan TE, Li CI. ”Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer.” Cancer Epidemiol Biomarkers Prev. 2011 Mar 1. [Epub ahead of print].
    40. Prentice RL. “Women's Health Initiative Studies of Postmenopausal Breast Cancer.” Adv Exp Med Biol 2008;617:151-60.
    41. Prentice RL, Shaw PA, Bingham SA, Beresford SAA, Caan B, Neuhouser ML, Patterson RE, Stefanick ML, Satterfield S, Thomson CA, Snetselaar L, Thomas A, Tinker LF. “Biomarker-Calibrated Energy and Protein Consumption and Increased Cancer Risk Among Postmenopausal Women.” Am J Epidemiol 2009 Mar 3. [Epub ahead of print]
    42. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA. “The Decrease in Breast-Cancer Incidence in 2003 in the United States.” N Engl J Med 2007 Apr 19;356(16):1670-4.
    43. Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, Paskett ED. ”Obesity in Relation to Endometrial Cancer Risk and Disease Characteristics in the Women's Health Initiative.” Gynecol Oncol. 2011 Feb 14. [Epub ahead of print].
    44. Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM. “Association of Nonmelanoma Skin Cancer with Second Malignancy." Cancer Jan 1, 2004;100(1):130-138.
    45. Rosenberg CA, Khandekar J, Greenland P, Rodabough RJ, McTiernan A. “Cutaneous Melanoma in Postmenopausal Women after Nonmelanoma Skin Carcinoma." Cancer 2006;106(3):654-663.
    46. Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ, Fuchs C. “Plasma Folate, Vitamin B6, Vitamin B12, and Homocysteine and Pancreatic Cancer Risk in Four Large Cohorts.” Cancer Res 2007 Jun 1;67(11):5553-60.
    47. Stefanick ML. “Risk-Benefit Profiles of Raloxifene for Women.” N Engl J Med 2006 Jul 13;355(2):190-2.
    48. Thomson CA, Neuhouser ML, Shikany JM, Caan BJ, Monk BJ, Mossavar-Rahmani Y, Sarto G, Parker LM, Modugno F, Anderson GL. “The Role of Antioxidants and Vitamin A in Ovarian Cancer: Results from the Women’s Health Initiative.” Nutr Cancer 2008;60(6):710-719.
    49. Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, Cushman M, Strickler HD, Kaplan RC, Wassertheil-Smoller S, Scherer PE, Ho GY. “A Prospective Study of Inflammation Markers and Endometrial Cancer Risk in Postmenopausal Hormone Non-Users.” Cancer Epidemiol Biomarkers Prev. 2011 Mar 17. [Epub ahead of print].
    50. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. “Circulating Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer in Four Prospective Cohorts.” Br J Cancer 2007 Jul 2;97(1):98-104. Epub 2007 May 29.
    51. Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS. “Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer.” Cancer Res 2007 Aug 15;67(16):7923-8.
    52. Wolpin BM, Kraft PL, Xu M, et al. “Variant ABO Blood Group Alleles, Secretor Status and Risk of Pancreatic Cancer: Results from the Pancreatic Cancer Cohort Consortium." Cancer Epidemiol Biomarkers Prev. 2010 Oct 22. [Epub ahead of print].
    53. Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL. “Incidence of Cervical Cytological Abnormalities With Aging in the Women's Health Initiative." Obstet Gynecol 2006;108(2):410-419.

    Cardiovascular

    1. Allison MA, Manson JE, Langer RD, Aragaki A, Smoller S, Lewis CE, Thomas A, Lawson W, Cochrane BB, Hsia J, Hunt JR, robinson J. “Association Between Different Measures of Blood Pressure and Coronary Artery Calcium in Postmenopausal Women.” Hypertension Nov 2008;52(5):833-840.
    2. Allison MA, Manson JE, Aragaki, et al. “Resting Heart Rate and Coronary Artery Calcium in Postmenopausal Women.” JWH2011 Mar 25. [Epub ahead of print].
    3. Berger JS, Brown DL, Burke GL, Oberman A, Kostis JB, Langer RD, Wong ND, Wassertheil-Smoller S. “Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease." Circ Cardiovasc Qual Outcomes." 2009 Mar 5. [Epub ahead of print.]
    4. Caan B, Neuhouser M, Aragaki A, Lewis CB, Jackson R, LeBoff MS, Margolis KL, Powell L, Uwaifo G, Whitlock E, Wylie-Rosett J, LaCroix A. “Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain.” Arch Intern Med 2007 May 14;167(9):893-902.
    5. Chen Z, Maricic M, Aragaki AK, Mouton C, Arendell L, Lopez AM, Bassford T, Chlebowski RT. “Fracture Risk Increases After Diagnosis of Breast or Other Cancers in Postmenopausal Women: Results From the Women’s Health Initiative.” Osteoporos Int 2008 Sep 3. [Epub ahead of print]
    6. Denes P, Larson JC, Lloyd-Jones DM, Prineas RJ, Greenland P. “Major and Minor ECG Abnormalities in Asymptomatic Women and Risk Of Cardiovascular Events and Mortality.” JAMA 2007 Mar 7;297(9):978-85.
    7. Howard BV, Criqui MH, Curb JD, Rodabough R, Safford MM, Santoro N, Wilson AC, Wylie-Rossett J. “Risk Factor Clustering in the Insulin Resistance Syndrome and its Relationship to Cardiovascular Disease in Postmenopausal White, Black, Hispanic, and Asian/Pacific Islander Women." Metabolism 2003;3:362-371.
    8. Howard BV, Kuller L, Langer R, Manson JE, Allen C, Assaf A, Cochrane BB, Larson JC, Lasser N, Rainford M, Van Horn L, Stefanick ML, Trevisan M. “Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women's Health Initiative Observational Study." Circulation 2005;111:1462-1470.
    9. Howard BV. “Dietary Fat and Cardiovascular Disease: Putting the Women's Health Initiative in Perspective.” Nutr Metab Cardiovasc Dis 2007 Mar;17(3):171-4. Epub 2007 Feb 21.
    10. Hsia J, Barad D, Margolis K, Rodabough R, McGovern PG, Limacher MC, Oberman A, Smoller S. “Usefulness of Prior Hysterectomy as an Independent Predictor of Framingham Risk Score (The Women's Health Initiative)." Am J Cardiol 2003;92:264-269.
    11. Hsia J, Aragaki A, Bloch M, LaCroix AZ, Wallace R. “Predictors of Angina Pectoris Versus Myocardial Infarction from the Women's Health Initiative Observational Study." Am J Cardiol 2004; 93:673-678.
    12. Hsia J, Klouj A, Prasad A, Burt J, Adams-Campbell L, Howard BV. “Progression of Coronary Calcification in Healthy Postmenopausal Women." BMC Cardiovascular Disorders 2004;4:21: http://www.biomedcentral.com/1471-2261/4/21.
    13. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR, for the Women's Health Initiative Investigators. “Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative." Circulation 2007;115:855-860.
    14. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, for the Women's Health Initiative Investigators. “Calcium/Vitamin D Supplementation and Cardiovascular Events." Circulation 2007;115:846-854.
    15. Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, Robinson JG, LaCroix AZ, Manson JE, Women's Health Initiative Research Group. "Resting Heart Rate as a Low Tech Predictor of Coronary Events in Women: Prospective Cohort Study." Br Med J 2009 Feb 3. [Epub ahead of print]
    16. Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, Robinson JG, LaCroix AZ, Manson JE, Women's Health Initiative Research Group. "Resting Heart Rate as a Low Tech Predictor of Coronary Events in Women: Prospective Cohort Study." Br Med J 2009 Feb 3. [Epub ahead of print].
    17. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, Sarto GE, Robbins J, Phillips L, Martin LW, O’Sullivan MJ, Jackson R, Rodabough RJ, and Stefanick ML. “Oophorectomy vs Ovarian Conservation with Hysterectomy: Cardiovascular Disease, Hip Fracture, and Cancer in the Women’s Health Initiative Observational Study.” Arch Intern Med. 2011;171(8):760-768.
    18. Kaplan RC, McGinn AP, Baird AE, Hendrix SL, Kooperberg C, Lynch J, Rosenbaum DM, Johnson KC, Strickler HD, Wassertheil-Smoller S. “Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational Study.” J Stroke Cerebrovasc Dis 2008 Nov-Dec;17(6):344-55.
    19. Khurana C, Rosenbaum CG, Howard BV, Adams-Campbell L, Detrano R, Klouj A, Hsia J. “Coronary Calcification in Black Women and White Women." Am Heart J 2003;145:724-729.
    20. Kim CK, McGorray SP, Bartholomew BA, March M, Dicken T, Wassertheil-Smoller S, Curb JD, Oberman A, Hsia J, Gardin J, Wong ND, Barton B, McMahon RP, Sheps DS. “Depressive Symptoms and Heart Rate Variability in Postmenopausal Women." Arch Intern Med 2005;165:1239-1244.
    21. Klein R, Deng Y, Klein BEK, Hyman L, Seddon J, Frank RN, Wallace RB, Hendrix SL, Kuppermann BD, Langer RD, Kuller L, Brunner R, Johnson KC, Thomas AM, Haan M. “Cardiovascular Disease, Its Risk Factors and Treatment, and Age-Related Macular Degeneration: Women's Health Initiative Sight Exam Ancillary Study." Am J Ophthalmol 2007;143(3):473-483.
    22. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, Perri MG, Sheps DS, Pettinger MB, Siscovick DS. “Walking Compared with Vigorous Exercise for the Prevention of Cardiovascular Events in Women." N Engl J Med 2002;347:716-725.
    23. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH, Howard BV, Assaf AR, Prentice R. “Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women." Arch Intern Med 2005;165:500-508.
    24. McCall-Hosenfeld JS, Freund KM, Legault C, Jaramillo SA, Cochrane BB, Manson JE, Wenger NK, Eaton CB, McNeeley SG, Rodriguez BL, Bonds D. “Sexual Satisfaction and Cardiovascular Disease: The Women’s Health Initiative.” Am J Med April 2008;121(4):295-301.
    25. McTigue K, Larson JC, Valoski A, Burke G, Kotchen J, Lewis CE, Stefanick ML, VanHorn L, Kuller L. “Mortality and Cardiac and Vascular Outcomes in Extremely Obese Women." JAMA 2006;296:79-86.
    26. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. “Long-Term Exposure to Air Pollution and Incidence of Cardiovascular Events in Women." NEJM 2007;356(5):447-458.
    27. Newhouser ML, Wassertheil-Smoller S, Thomson C, Aragaki A, Anderson GL, Manson J, Patterson R, Rohan TE, van Horn L, Shikany JM, Thomas A, LaCroix A, Prentice R."Multivitamin Use and risk of Cancer and Cardiovascular Disease in the Women's Health Initiative Cohorts." Arch Intern Med 2009 Feb 9;169(3):294-304.
    28. Oberman A, Prineas RJ, Larson JC, LaCroix A, Lasser NL. “Prevalence and Determinants of Electrocardiographic Left Ventricular Hypertrophy Among a Multiethnic Population of Postmenopausal Women (The Women's Health Initiative)." Am J Cardiol 2006;97:512-519.
    29. Pradhan A, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM, Ridker PM. “Tissue Plasminogen Activator Antigen and D-Dimer as Markers for Atherothrombotic Risk Among Healthy Postmenopausal Women." Circulation 2004;110:292-300.
    30. Prentice RL, Huang Y, Kuller LH, Tinker LF, Horn LV, Stefanick ML, Sarto G, Ockene J, Johnson KC. “Biomarker-calibrated Energy and Protein Consumption and Cardiovascular Disease Risk Among Postmenopausal Women.” Epidemiology. 2011 Jan 4. [Epub ahead of print].
    31. Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. “Electrocardiographic Abnormalities That Predict Coronary Heart Disease Events and Mortality in Postmenopausal Women: The Women's Health Initiative." Circulation 2006;113(4):473-480.
    32. Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. “Electrocardiographic Predictors of Incident Congestive Heart Failure and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative." Circulation 2006;113(4):481-489.
    33. Rautaharju PM, Prineas RJ, Kadish A, Larson JC, Hsia J, Lund B. “Normal Standards for QT and QT Subintervals Derived from a Large Ethnically Diverse Population of Women Aged 50 to 79 Years: The Women's Health Initiative." Am J Cardiol 2006;97:730-737.
    34. Robinson JG, Wallace R, Limacher M, Sato A, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG. “Elderly Women Diagnosed with Nonspecific Chest Pain May be at Increased Cardiovascular Risk." Journal of Women's Health 2007;15(10):1151-1160.
    35. Robinson JG, Wallace R, Limacher M, Ren H. Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG. “Cardiovascular Risk in Women with Non-Specific Chest Pain from the Women’s Health Initiative Hormone Trials.” Am J Cardiol Sep 2008;102(6):693-699.
    36. Schnall E, Wassertheil-Smoller S, Swencionis C, Zemon V, Tinker L, O’Sullivan MJ, Van Horn L, Goodwin M. “The Relationship between Religion and Cardiovascular Outcomes and All-Cause Mortality in the Women’s Health Initiative Observational Study.” Psychol Health 2008 Nov 17. [Epub ahead of print].
    37. Schwarz EB, Ray RM, Stuebe AM, Allison MA, Ness RB, Freiberg MS, Cauley JA. "Duration of Lactation and Risk Factors for Maternal Cardiovascular Disease." Obstet Gynecol 2009 May;113(5):974-982.
    38. Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D. “Panic Attacks and Risk of Incident Cardiovascular Events among Postmenopausal Women in the Women's Health Initiative Observational Study." Arch Gen Psychiatry 2007;64:1153-1160.
    39. Smoller JW, Pollack MH, Wassertheil-Smoller S, Brunner R, Curb D, Torner J, Oberman A, Hendrix SL, Hsia J, Sheps DS. “Panic Attacks, Daily Life Ischemia, and Chest Pain in Postmenopausal Women.” Psychosom Med 2006 Nov-Dec;68(6):824-32.
    40. Szmuilowicz ED, Manson JE, Rossouw JE, Howard BV, Margolis KL, Greep NC, Brzyski RG, Stefanick ML, O'Sullivan MJ, Wu C, Allison M, Grobbee DE, Johnson KC, Ockene JK, Rodriguez BL, Sarto GE, Vitolins MZ, Seely EW. ”Vasomotor Symptoms and Cardiovascular Events in Postmenopausal Women.” Menopause.” 2011 Feb 19. [Epub ahead of print].
    41. Tindle HA, Chang YF, Kuller LH, Manson JE, Robinson JG, Rosal MC, Siegle GJ, Matthews KA. “Optimism, Cynical Hostility, and Incident Coronary Heart disease and Mortality in the women's Health Initiative." Circulation. 2009 August 10. [Epub ahead of print]
    42. Wang L, Manson JE, Gaziano JM, Liu S, Cochrane B, Cook NR, Ridker PM, Rifai N, and Sesso HD. ”Circulating Inflammatory and Endothelial Markers and Risk of Hypertension in White and Black Postmenopausal Women.” Clin Chem. 2011 Mar 11. [Epub ahead of print].
    43. Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, Francis J, Grimm R, Kotchen T, Langer R, Lasser N. “Hypertension and Its Treatment in Postmenopausal Women: Baseline Data from the Women's Health Initiative." Hypertension 2000;36:780-789.
    44. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. “Depression and Cardiovascular Sequelae in Postmenopausal Women: The Women's Health Initiative (WHI)." Arch Intern Med. 2004;164:289-298.
    45. Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M. “Association Between Cardiovascular Outcomes and Antihypertensive Drug Treatment in Older Women." JAMA 2004;292:2849-2859.
    46. Wenger NK. “Do diet, folic acid, and vitamins matter? What Did We Learn From the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and Other Clinical Trials?” Cardiol Rev 2007 Nov-Dec;15(6):288-90.
    47. Whitsel EA, Quibrera PM, Christ SL, Liao D, Prineas RJ, Anderson GL, Heiss G. “Heart Rate Variability, Ambient Particulate Matter Air Pollution, and Glucose Homeostasis: The Environmental Epidemiology of Arrhythmogenesis in the Women's Health Initiative." Am J Epidemiol 2009 Feb 10. [Epub ahead of print]
    48. Zhang Z, Whitsel EA, Quibrera PM, Smith RL, Liao D, Anderson GL, Prineas RJ. “Ambient Fine Particulate Matter Exposure and Myocardial Ischemia in the Environmental Epidemiology of Arrhythmogenesis in the Women's Health Initiative (EEAWHI)." Environ Health Perspect 2009 Jan 23. [Epub ahead of print]

    Cognition and Dementia

    1. Atkinson HH, Rapp SR, Williamson JD, Lovato J, Absher JR, Gass M, Henderson VW, Johnson KC, Kostis JB, Sink KM, Mouton CP, Ockene JK, Stefanick ML, Lane DS, Espeland MA. “The Relationship Between Cognitive function and Physical Performance in Older Women: Results from the Women's Health Initiative Memory Study."J Gerontol A Biol Sci Med Sci. 2009 Sep 29. [Epub ahead of print].
    2. Driscoll I, Espeland MA, Wassertheil-Smoller S, Gaussoin SA, Ding J, Granek IA, Ockene JK, Phillips LS, Yaffe K, Resnick SM. ”Weight Change and Cognitive Function: Findings from the Women’s Health Initiative Study of Cognitive Aging.” Obesity (Silver Spring). 2011 Mar 10. [Epub ahead of print].
    3. Dunn JE, Weintraub S, Stoddard AM, Banks S. “Serum Alpha-Tocopherol, Concurrent and Past Vitamin E Intake, and Mild Cognitive Impairment.” Neurology 2007 Feb 27;68(9):670-6.
    4. Espeland MA, Gu L, Masaki KH, Langer RD, Coker LH, Stefanick ML, Ockene J, Rapp SR. “Association between Reported Alcohol Intake and Cognition: Results from the Women's Health Initiative Memory Study." Am J Epidemiol 2005;161:228-238.
    5. Espeland MA, Rapp SR, Robertson J, Granek I, Murphy C, Albert M, Bassford T. “Benchmarks for Designing Two-Stage Studies Using Modified Mini-Mental State Examinations: Experience from the Women's Health Initiative Memory Study." Clinical Trials 2006;3:99-106.
    6. Espeland MA, Coker LH, Wallace R, Rapp SR, Resnick SM, Limacher M, Powell LH, Messina CR; Women's Health Initiative Study of Cognitive Aging. “Association Between Alcohol Intake and Domain-Specific Cognitive Function in Older Women.” Neuroepidemiology 2006;27(1):1-12.
    7. Gaussoin SA, Espeland MA, Absher J, Howard BV, Jones BM, Rapp SR. “Ascertaining Dementia-Related Outcomes for Deceased or Proxy-Dependent Participants: An Overview of the Women's Health Initiative Memory Study Supplemental Case Ascertainment Protocol.” Int J Geriatr Psychiatry. 2011 Mar 18. Epub ahead of print].
    8. Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S, Kotchen JM. ”Depressive Symptoms and Incidence of Mild Cognitive Impairment and Probable Dementia in Elderly Women: The Women’s Health Initiative Memory Study.” J Am Geriatr Soc. 2011 Jan;59(1):57-66.
    9. Goveas JS, Espeland MA, Hogan P, Dotson V, Tarima S, Coker LH, Ockene J, Brunner R, Woods NF, Wassertheil-Smoller S, Kotchen JM, Resnick S. ”Depressive Symptoms, Brain Volumes and Subclinical Cerebrovascular Disease in Postmenopausal Women: The Women's Health Initiative MRI Study.” J Affect Disord. 2011 Feb 23. [Epub ahead of print].
    10. Jaramillo SA, Felton D, Andrews L, Desiderio L, Hallarn RK, Jackson SD, Coker LH, Robinson JG, Ockene JK, Espeland MA; Women's Health Initiative Memory Study Research Group. “Enrollment in a Brain Magnetic Resonance Study: Results from the Women’s Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI).” Acad Radiol 2007 May;14(5):603-12.
    11. Johnson KC, Margolis KL, Espeland MA, Colenda CC, Fillit H, Manson JE, Masaki KH, Mouton CP, Prineas R, Robinson JG, Wassertheil-Smoller S; for the Women’s Health Initiative Memory Study and Women’s Health Initiative Investigators. “A Prospective Study of the Effect of Hypertension and Baseline Blood Pressure on Cognitive Decline and Dementia in Postmenopausal Women: The Women’s Health Initiative Memory Study.” J Am Geriatr Soc 2008 Jul 15. [Epub ahead of print].
    12. Kerwin DR, Gaussoin SA, Chlebowski RT, Kuller LH, Vitolins M, Coker LH, Kotchen JM, Nicklas BJ, Wassertheil-Smoller S, Hoffmann RG, Espeland MA; for the Women's Health Initiative Memory Study. ”Interaction Between Body Mass Index and Central Adiposity and Risk of Incident Cognitive Impairment and Dementia: Results from the Women's Health Initiative Memory Study.” J Am Geriatr Soc. 2011 Jan;59(1):107-112.
    13. Rapp S, Espeland M, Hogan P, Jones B, Dugan E.  “Baseline Experience with Modified Mini Mental State Exam: The Women's Health Initiative Memory Study (WHIMS)." Aging and Mental Health 2003;7(3):217-223.
    14. Rapp S, Espeland M, Shumaker S, Henderson V, Brunner R, Manson J, Gass M, Stefanick M, Lane D, Hays J, Johnson K, Coker L, Dailey M, Bowen D. “Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial." JAMA 2003;289:2663-2672.
    15. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA. “Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect." J Clin Endocrinol Metab 2006;91:1802-1810.
    16. Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA. “The Women's Health Initiative Study of Cognitive Aging (WHISCA): A Randomized Clinical Trial of the Effects of Hormone Therapy on Age-Related Cognitive Decline." Clinical Trials 2004;1:440-450.
    17. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN. “The Women's Health Initiative Memory Study (WHIMS): A Trial of the Effect of Estrogen Therapy in Preventing and Slowing the Progression of Dementia". Control Clin Trials 1998;Dec;19(6):604-621.
    18. Shumaker S, Legault C, Thal L, Wallace R, Ockene J, Hendrix S, Jones III B, Assaf A, Jackson R, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. “Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial." JAMA 2003;289:2651-2662.
    19. Shumaker S, Legault C, Kuller L, Rapp S, Thal L, Lane D, Fillit H, Stefanick M, Hendrix S, Lewis CB, Masaki K, Coker L. “Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women." JAMA 2004;291:2947-2958.

    Design and Methods

    1. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang C, Stein E, Prentice R. “Baseline Monograph - Implementation of the WHI Study Design." Ann Epidemiol 2003;13:S5-S17.
    2. Anderson GL, Kooperberg C, Geller N, Rossouw JE, Pettinger M, Prentice RL. “Monitoring and Reporting of The Women’s Health Initiative Randomized Hormone Therapy Trials.” ClinTrials 2007;4(3):207-17.
    3. Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, Lewis CE, Kipersztok S, Borne C, Jackson R. “Validity of Self-Report for Fractures Among a Multiethnic Cohort of Postmenopausal Women: Results from the Women's Health Initiative Observational Study and Clinical Trials." Menopause 2004;11(3):264-274.
    4. Cochrane BB, Lund B, Anderson S, Prentice R (2003). “The Women's Health Initiative: Aspects of Management and Coordination." In J. W. Hawkins, L. A. Haggerty (Eds.): Diversity in Health Care Research: Strategies for Multisite, Multidisciplinary, and Multi-Ethnic Projects (pp. 181-207). New York:Springer.
    5. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S. “Outcomes Ascertainment and Adjudication Methods in the Women's Health Initiative." Ann Epidemiol 2003;13:S122-S128.
    6. Fouad MN, Corbie-Smith G, Curb D, Howard BV, Mouton C, Simon M, Talavera G, Thompson J, Wang CY, White C, Young R. “Special Populations Recruitment for the Women's Health Initiative: Successes and Limitations." Controlled Clinical Trials 2004;25:325-352.
    7. Freedman L, Anderson G, Kipnis V, Prentice R, Wang CY, Rossouw J, Wittes J, DeMets D. “Approaches to Monitoring the Results of Long-Term Disease Prevention Trials: Examples from the Women's Health Initiative." Controlled Clinical Trials 1996;17:509-525.
    8. Gorfine, Hsu, Prentice. “Estimation of Dependence between Paired Correlated Failure Times in the Presence of Covariate Measurement Error." Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2003;65(3):643.
    9. Gorfine M, Lipshtat N, Freedman LS, Prentice RL. “Linear Measurement Error Models with Restricted Sampling.” Biometrics 2007 Mar;63(1):137-42.
    10. Hays J, Hunt J, Hubbell A, Anderson G, Limacher M, Allen C, Rossouw J. “The WHI Recruitment Methods and Results." Ann Epidemiol 2003;13:S18-S77.
    11. Hebert JR, Patterson RE, Gorfine M, Ebbeling CB, St. Jeor ST, Chlebowski RT. “Differences between Estimated Caloric Requirements and Self-Reported Caloric Intake in the Women's Health Initiative." Ann Epidemiol 2003;13(9):629-637.
    12. Heckbert S, Kooperberg C, Safford M, Psaty B, Hsia J, McTiernan A, Gaziano M, Frishman W, Curb JD. “Comparison of Self-Report, Discharge Diagnosis, and Adjudication of Cardiovascular Events in the WHI." Am J Epidemiol 2004;160:1152-1158.
    13. Johnson SR, Anderson GL, Barad DH, Stefanick ML. “The Women's Health Initiative: Rationale, Design, and Progress Report." Journal of the British Menopause Society 1999;5:155-159.
    14. Larkey LK, Staten LK, Ritenbaugh C, Hall RA, Buller DB, Bassford T, Altimari BR. “Recruitment of Hispanic Women to the Women's Health Initiative: The Case of Embajadoras in Arizona." Controlled Clinical Trials 2002;23:289-298.
    15. Levine DW, Shumaker SA, Naughton MJ, Kaplan RM, Kripke DF, Bowen DJ. “Factor Structure and Measurement Invariance of the Women's Health Initiative Insomnia Rating Scale." Psychological Assessment 2003;15(2):123-136.
    16. Levine DW, Kaplan RM, Kripke DF, Bowen DJ, Naughton MJ, Shumaker SA. “Reliability and Validity of the Women's Health Initiative Insomnia Rating Scale." Psychological Assessment 2003;15(2):137-148.
    17. Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA. “Validation of the Women's Health Initiative Insomnia Rating Scale in a Multicenter Controlled Clinical Trial." Psychosomatic Medicine 2005;67:98-104.
    18. Matthews KA, Shumaker SA, Bowen DJ, Langer RD, Hunt JR, Kaplan RM, Klesges RC, Ritenbaugh C. “Women's Health Initiative. Why now? What is it? What's new?" American Psychologist 1997;52:101-116.
    19. McTiernan A, Rossouw J, Manson J, Franzi C, Taylor V, Carleton R, Johnson S, Nevitt M. “Informed Consent in the Women's Health Initiative Clinical Trial and Observational Study." Journal of Women's Health 1995;4:519-529.
    20. Mossavar-Rahmani Y, Henry H, Rodabough R, Bragg C, Brewer A, Freed T, Kinzel L, Pedersen M, Soule O, Vosburg S. “Additional Self-Monitoring Tools in the Dietary Modification Component of the Women's Health Initiative." J Am Diet Assoc 2004;104:76-85.
    21. Patterson RE, Kristal AR, Coates RJ, Tylavsky FA, Ritenbaugh C, Van Horn L, Caggiula AW, Snetselaar L. “Low-Fat Diet Practices of Older Women: Prevalence and Implications for Dietary Assessment." Journal of the American Dietetic Association 1996;96:670-679.
    22. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. “Measurement Characteristics of the Women's Health Initiative Food Frequency Questionnaire." Ann Epidemiol 1999;Apr;9(3):178-187.
    23. Prentice RL, Anderson G, Cummings S, Freedman LS, Furberg C, Henderson M, Johnson SR, Kuller L, Manson J, Oberman A, Prentice RL, Rossouw JE. “Design of the Women's Health Initiative Clinical Trial and Observational Study." Controlled Clinical Trials 1998;19:61-109.
    24. Prentice R, Rossouw JR, Johnson, SR, Freedman LS, McTiernan A. “The Role of Randomized Controlled Trial's in Assessing the Benefits and Risks of Long-Term Hormone Replacement Therapy: Example of the Women's Health Initiative." Menopause, 1996;3:71-76.
    25. Prentice RL. “Observational Studies, Clinical Trials, and the Women's Health Initiative.” Lifetime Data Anal 2007 Dec;13(4):449-62.
    26. Rossouw JE, Finnegan LP, Harlan WR, Pinn VW, Clifford C, McGowan JA. “The Evolution of the Women's Health Initiative: Perspectives from the NIH." Journal of the American Medical Women's Association 1995;50:50-55.
    27. Rossouw JE, Hurd S. “The Women's Health Initiative: Recruitment Complete--Looking Back and Looking Forward." J Women's Health 1999;Jan-Feb;8(1):3-5.
    28. Rossouw JE, Anderson GL, Oberman A. “Baseline Monograph - Forword." Ann Epidemiol 2003;13:S1-S4.
    29. Tinker LF, Burrows ER, Henry H, Patterson R, Rupp J, Van Horn L. “The Women's Health Initiative: Overview of the Nutrition Components." In: Nutrition and Women's Health, D.A. Krummel and P.M. Kris-Etherton eds., Gaithersburg, MD, Aspen Publishers, pp. 510-542, 1996.
    30. Wang CY, Anderson G, Prentice R. “Estimation of the Correlation Between Nutrient Intake Measures Under Restricted Sampling." Biometrics 1999;55:711-717.
    31. Wilcox S, Shumaker SA, Bowen DJ, Naughton MJ, Rosal MC, Ludlam SE, Dugan E, Hunt JR, Stevens S. “Promoting Adherence and Retention to Clinical Trials in Special Populations: A Women's Health Initiative Workshop." Controlled Clinical Trials 2001;22(3):279-289.
    32. Yang S, Prentice R. “Estimation of the 2-Sample Hazard Ratio Function Using a Semiparametric Model.” Biostatistics. 2011 Apr;12(2):354-68.
    33. Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL. “Frequency and Predictive Value of a Mammographic Recommendation for Short-Interval Follow-Up." J Natl Cancer Inst 2003;95:429-436.

    Diet

    1. Beresford SAA, Johnson KC, Ritenbaugh C et al. “Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial." JAMA 2006;295:643-654.
    2. Bowen DJ, Ehret C, Pederson M, Snetselaar L, Johnson M, Tinker L, Hollinger D, Lichty I, Bland K, Sivertsen D, Ocken D, Staats L, Beedoe JW. “Results of an Adjunct Dietary Intervention Program in the Women's Health Initiative." JADA 2002;102:1631-1637.
    3. Carty CL, Kooperberg C, Neuhouser ML, Tinker L, Howard B, Wactawski-Wende J, Beresford SA, Snetselaar L, Vitolins M, Allison M, Budrys N, Prentice R, and Peters U. “Low-Fat Dietary Pattern and Change in Body-Composition Traits in the Women's Health Initiative Dietary Modification Trial." Am J Clin Nutr. 2010 Dec 22. [Epub ahead of print].
    4. Casso D, White E, Patterson RE, Agurs-Collins T, Kooperberg C, Haines PS. “Correlates of Serum Lycopene in Older Women." Nutrition and Cancer 2000;36:163-169.
    5. Glanz K, Murphy S, Moyan J, Evensen D, Curb JD. “Improving Dietary Self-Monitoring and Adherence with Hand-Held Computers: A Pilot Study." AJHP 2006;20(3):165-170.
    6. Howard BV, Manson JE, Stefanick ML, Beresford SA, Frank G, Jones B, Rodabough RJ, Snetselaar L, Thomson C, Tinker L, Vitolins M, Prentice R. “Low-Fat Dietary Pattern and Weight Change Over 7 Years: The Women's Health Initiative Dietary Modification Trial." JAMA 2006;295:39-49.
    7. Howard BV, Van Horn L, Hsia J, et al. “Low-Fat dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial." JAMA 2006;295:655-666.
    8. Hsia J, Rodabough R, Rosal M, Cochrane B, Howard BV, Snetselaar L, Frishman WH, Stefanick ML. “Compliance with National Cholesterol Education Program Dietary and Lifestyle Guidelines among Older Women with Self-Reported Hypercholesterolemia: The Women's Health Initiative." Am J Med 2002;113:384-392.
    9. Kabat GC, Shikany JM, Beresford SAA, Caan B, Neuhouser ML, Tinker LF, Rohan TE. “Dietary Carbohydrate, Glycemic Index, and Glycemic Load in Relation to Colorectal Cancer Risk in the Women’s Health Initiative.” Cancer Causes Control 2008 Jul 10. [Epub ahead of print]
    10. Keith SW, Wang C, Fontaine KR, Cowan CD, Allison DB. “BMI and Headache Among Women: Results from 11 Epidemiologic Datasets.” Obesity (Silver Spring) 2008 Feb;16(2):377-83.
    11. Ma Y, Hebert JR, Li W, Bertone-Johnson ER, Olendzki B, Pagoto SL, Tinker L, Rosal MC, Ockene IS, Ockene JK, Griffith JA, Liu S. “Association between Dietary Fiber and Markers of Systemic Inflammation in the Women’s Health Initiative Observational Study.” Nutrition Oct 2008;24(10):941-949.
    12. Manson JE, Lewis CE, Kotchen JM, Allen C, Johnson KC, Stefanick M, Foreyt J, Klesges R, Tinker L, Noonan E, Perri M, Hall D. “Ethnic, Socioeconomic, and Lifestyle Correlates of Obesity in U.S. Women: The Women's Health Initiative." Clinical Journal of Women's Health 2001;1(5)225-234
    13. McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY, Women's Health Initiative Investigators. “Relation of BMI and Physical Activity to Sex Hormones in Postmenopausal Women.” Obesity (Silver Spring) 2006 Sep;14(9):1662-77.
    14. McTiernan A, Wactawski-Wende J, Wu L, Rodabough RJ, Watts NB, Tylavsky F, Freeman R, Hendrix S, Jackson R. "Low-Fat, Increased Fruit, Vegetable, and Grain Dietary Pattern, Fractures, and Bone Mineral Density: The Women's Health Initiative Dietary Modification Trial." Am J Clin Nutr April 29, 2009 [Epub ahead of print].
    15. Mossavar-Rahmani Y & Tinker LF. “Women’s Health Initiative Dietary Modification Randomized Controlled Trial.” In: D'Agostino RB et al, eds. Wiley encyclopedia of clinical trials. New York: Wiley-Interscience, 2008.
    16. Neuhouser M, Tinker LF, Thomson C, Caan B, Van Horn L, Snetselaar L, Parker LM, Patterson RE, Robinson-O'Brien R, Beresford SAA, Shikany JM. “Development of a Glycemic Index Database for Food Frequency Questionnaires Used in Epidemiologic Studies." J Nutr 2006;136:1604-1609.
    17. Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Van Horn L, Beresford SAA, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, Stefanick ML, Assaf A, Runswick S, Prentice RL. “Use of Recovery Biomarkers to Calibrate Nutrient Consumption Self-Reports in the Women’s Health Initiative.” Am J Epidemiol<\i> 2008;167(10):1247-1259.
    18. Patterson R, Caan B, Kristal A, Lillington L, Mossavar-Rahmani Y, Rodabough R, Simon M, Snetselaar L, Van Horn L. “Changes in Food Sources of Dietary Fat in Response to Intensive Low-Fat Dietary Intervention: Early Results from the Women's Health Initiative." JADA April 2003;103:454-459.
    19. Prentice RL, Caan B, Chlebowski R, et al. “Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial." JAMA 2006;295:629-642.
    20. Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SAA, Pettinger M, Lane DS, Lessin L, Yasmeen S, Singh B, Khandekar J, Shikany JM, Satterfield S, Chlebowski RT. “Low-Fat Dietary Pattern and Cancer Incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial." J Natl Cancer Inst 2007;99:1534-1543.
    21. Ritenbaugh C, Patterson R, Chlebowski R, Caan B, Tinker L, Howard B, Ockene J. “The WHI DM Trial: Overview and Baseline Characteristics of Participants." Ann Epidemiol 2003;13:S87-S97.
    22. Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, Ginsberg M, Lane DS, Neuhouser ML, Shikany JM, Wassertheil-Smoller S, Page DL. “Low-Fat Dietary Pattern and Risk of Benign Proliferative Breast Disease: A Randomized, Controlled Dietary Modification Trial.” Cancer Prev Research 2008 Jul 9. [Epub ahead of print].
    23. Shikany JM, Margolis KL, Pettinger M, Jackson RD, Limacher MC, Liu S, Phillips LS, and Tinker LF. “Effects of a Low-Fat dietary Intervention on Glucose, Insulin, and Insulin Resistance in the Women's Health Initiative (WHI) Dietary Modification Trial.” Am J Clin Nutr. 2011 May 11. [Epub ahead of print].
    24. Thomson CA, Stanaway JD, Neuhouser ML, et al. “Nutrient Intake and Anemia Risk in the Women’s Health Initiative Observational Study.” J Am Diet Assoc. 2011;111:532-541.
    25. Tinker LF, Rosal MC, Young AF, Perri MG, Patterson RE, Van Horn L, Assaf AR, Bowen DJ, Ockene J, Hays J, Wu L. “Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial.” J Am Diet Assoc 2007 Jul;107(7):1155-65.
    26. Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, Perri MG, Beresford SAA, Robinson JG, Rodriguez B, Safford MM, Wenger NK, Stevens VJ, Parker LM. “Low-Fat Dietary Pattern and Risk of Treated Diabetes Mellitus in Postmenopausal Women: The Women’s Health Initiative Randomized Controlled Dietary Modification Trial.” Arch Intern Med Jul 2008;168(14):1500-1511.
    27. Women's Health Initiative Study Group. “Dietary Adherence in the Women's Health Initiative Dietary Modification Trial." J Am Diet Assoc April 2004;104(4):654-658.

    Hormone Therapy

    1. Allison MA, Manson JE. “Hormone Replacement Therapy.” In: Encyclopedia of Epidemiology. Thousand Oaks, CA: Sage Publications,2007:503-10.
    2. Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillips L, Cochrane BB, Eaton CB, Greenland P, Hendrix S, Hsia J, Hunt JR, Jackson RD, Johnson KC, Kuller LH, Robinson J; Women's Health Initiative and Women's Health Initiative Coronary Artery Calcium Study Investigators. “Oophorectomy, Hormone Therapy, and Subclinical Coronary Artery Disease in Women with Hysterectomy: The Women's Health Initiative Coronary Artery Calcium Study.” Menopause 2008 Jul-Aug;15(4 Pt 1): 639-47.
    3. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SAA, Pettinger M, Jiu J, McNeeley SG, Lopez AM. “Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic Procedures: The Women's Health Initiative Randomized Trial." JAMA 2003;290:1739-1748.
    4. Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, Curb JD, Hendrix SL, Hubbell FA, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C. “Prior Hormone Therapy and Breast Cancer Risk in the Women's Health Initiative Randomized Trial of Estrogen Plus Progestin." Maturitas 2006;55:103-115.
    5. Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB. “Prior Oral Contraception and Postmenopausal Fracture: A Women's Health Initiative Observational Cohort Study." Fertil Steril 2005;84(2):374-383.
    6. Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR. “Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Women's Health Initiative." Obstet Gynecol 2005;105:1063-73.
    7. Bonds D, Lasser N, Qi L, Brzyski R, Caan B, Heiss G, Limacher MC, Liu JG, Mason E, Oberman A, O'Sullivan MJ, Phillips LS, Prineas RJ, Tinker L. “The Effect of Conjugated Equine Oestrogen on Diabetes Incidence: The Women's Health Initiative Randomised Trial." Diabetologia 2006;49:459-468.
    8. Bray PF, Larson JC, LaCroix AZ, Manson J, Limacher MC, Rossouw JE, Lasser NL, Lawson WE, Stefanick ML, Langer RD, Margolis KL; Women's Health Initiative Investigators. “Usefulness of Baseline Lipids and C-Reactive Protein in Women Receiving Menopausal Hormone Therapy as Predictors of Treatment-Related Coronary Events.” Am J Cardiol 2008 Jun 1;101(11):1599-1605.
    9. Brunner RL, Gass M, Aragaki A, Hays J, Granek I, Woods N, Mason E, Brzyski R, Ockene J, Assaf A, LaCroix A, Matthews K, Wallace R. “Effects of Conjugated Equine Estrogen on Health-Related Quality of Life in Postmenopausal Women with Hysterectomy: Results from the Women's Health Initiative Randomized Clinical Trial." Arch Intern Med 2005;165:1976-1986.
    10. Casanova R, Espeland MA, Goveas JS, Davatzikos C, Gaussoin SA, Maldjian JA, Brunner RL, Kuller LH, Johnson KC, Mysiw WJ, Wagner B, Resnick SM; for the Women's Health Initiative Memory Study. ”Application of Machine Learning Methods to Describe the Effects of Conjugated Equine Estrogens Therapy on Region-Specific Brain Volumes.” Magn Reson Imaging. 2011 Feb 1. [Epub ahead of print].
    11. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB. “Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density." JAMA 2003;290(13):1729-1738.
    12. Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL. “Postmenopausal Hormone Therapy and Body Composition--A Substudy of the Estrogen Plus Progestin Trial of the Women's Health Initiative." Am J Clin Nutr 2005;82:651-6.
    13. Chen Z, Beck T, Cauley JA, Lewis CE, LaCroix A, Bassford T, Wu G, Sherrill D, Going S. “Hormone Therapy Improves Femur Geometry Among Ethnically Diverse Postmenopausal Participants in the Women’s Health Initiative Hormone Intervention Trials.” J Bone Miner Res Dec 2008;23(12):1935-1945.
    14. Chlebowski R, Hendrix SL, Langer RD, Stefanick M, Gass M, Lane D, Rodabough R, Gilligan MA, Cyr M, Thomson C, Khandekar J, Petrovitch H, McTiernan A. “Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: the Women's Health Initiative Randomized Trial." JAMA 2003;289:3243-3253.
    15. Chlebowski RT, Kim JA, Col NF. “Estrogen Deficiency Symptom Management in Breast Cancer Survivors in the Changing Context of Menopausal Hormone Therapy." Seminars in Oncology (December) 2004;30(6):776-788.
    16. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rondabough RJ, Rosenberg CA, Taylor VM, Harris R, Chan C, Adams-Campbell LL, White E. “Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women." N Engl J Med 2004;350:991-1004.
    17. Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, for the Women's Health Initiative Investigators. “Predicting Risk of Breast Cancer in Postmenopausal Women by Hormone Receptor Status." J Natl Cancer Inst 2007;99:1695-1705.
    18. Chlebowski RT, Anderson G, Pettinger M, Lane D, Langer RD, Gillian MA, Walsh BW, Chen C, McTiernan A, for the Women's Health Initiative Investigators. “Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy." Arch Intern Med. 2008;168(4):370-377.
    19. Chlebowski RT, Prentice RL. “Menopausal Hormone Therapy in BRACA1 Mutation Carriers: Uncertainty and Caution.” JNCI 2008 Sep 23. [Epub ahead of print]
    20. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G, Women's Health Initiative Investigators. "Breast Cancer After Use of Estrogen plus Progestin in Postmenopausal Women." N Engl J Med 2009 Feb 5;360(6):573-587.
    21. Cirillo D, Wallace R, Rodabough R, Greenland P, LaCroix A, Limacher M, Larson J. “Effect of Estrogen Therapy on Gallbladder Disease." JAMA 2005;293(3):330-339.
    22. Cirillo DJ, Wallace RB, Wu LL, Yood RA. “Effect of Hormone Therapy on Risk of Hip and Knee Replacement in the Women's Health Initiative." Arthritis & Rheumatism 2006;54(10):3194-3204.
    23. Coker LH, Hogan PE, Bryan NR, Kuller LH, Margolis KL, Bettermann K, Wallace RB, Lao Z, Freeman R, Stefanick ML, Shumaker SA. “Postmenopausal Hormone Therapy and Subclinical Cerebrovascular Disease: The WHIMS-MRI Study." Neurology 2009;72(2):125-134.
    24. Col NF, Chlebowski RT. “Risks and Benefits of Therapy with Menopausal Hormones Versus Selective Estrogen-Receptor Modulators in Peri- and Postmenopausal Women at Increased Breast Cancer Risk.” Menopause 2008 Jul-Aug;15(4 Suppl):804-9.
    25. Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Gyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR. “Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus." Arch Intern Med 2006;166:772-780.
    26. Curtis JR, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, Judd S, Safford M, Solomon DH, LaCroix AZ. “Placebo Adherence, Clinical Outcomes, and Mortality in the Women’s Health Initiative Randomized Hormone Therapy Trials.” Med Care. 2011 Mar 18. [Epub ahead of print].
    27. Cushman M, Kuller L, Prentice R, Rodabough R, Psaty B, Stafford R, Sidney S, Rosendaal F. “Estrogen Plus Progestin and Risk of Venous Thrombosis." JAMA 2004;292(13):1573-1580.
    28. Espeland M, Rapp S, Shumaker S, Brunner R, Manson J, Sherwin B, Hsia J, Margolis K, Hogan P, Wallace R, Dailey M, Freeman R, Hays J. “Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women." JAMA 2004;291:2959-2968.
    29. Espeland MA, Tindle HA, Bushnell CA, Jaramillo SA, Kuller LH, Margolis KL, Mysiw WJ, Maldjian JA, Melhem ER, Resnick SM, and for the Women's Health Initiative Memory Study. “Brain Volumes, Cognitive Impairment, and Conjugated Equine Estrogens.” J Gerontol A Biol Sci Med Sci.2009 September 3. [Epub ahead of print]
    30. Haan MN, Klein R, Klein BE, Deng Y, Blythe LK, Seddon JM, Musch DC, Kuller LH, Hyman LG, Wallace RB. “Hormone Therapy and Age-Related Macular Degeneration: The Women's Health Initiative Sight Exam Study." Arch Ophthalmol 2006;124:988-992.
    31. Hays J, Ockene J, Brunner R, Kotchen J, Manson J, Patterson R, Aragaki A, Shumaker S, Brzyski R, LaCroix A, Granek I, Valanis B. “Effects of Estrogen plus Progestin on Health-Related Quality of Life." NEJM May 2003;348:1839-54.
    32. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SAA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, for the WHI Investigators. “Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin." JAMA 2008;299(9):1036-1045.
    33. Hendrix S, Prentice R. “WHI Response to Goodman, Goldzieher and Ayala's Critique of the Women's Health Initiative Report on the Risks and Benefits of Estrogen Plus Progestin." Menopausal Medicine 2003;11:1-4.
    34. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG. “Effects of Estrogen With and Without Progestin on Urinary Incontinence." JAMA 2005;293(8):935-948.
    35. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J. “Effects of Conjugated Equine Estrogen on Stroke in the Women's Health Initiative." Circulation 2006;113:2425-2434.
    36. Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM. “Estrogen Plus Progestin and the Risk of Peripheral Arterial Disease: The Women's Health Initiative." Circulation February 10, 2004;109(5):620-626.
    37. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R. “Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative." Arch Intern Med 2006;166:357-365.
    38. Hsia J, Criqui MH, Herrington DM, Manson JE, Wu L, Heckbert SR, Allison M, McDermott MM, Robinson J, Masaki K. “Conjugated Equine Estrogens and Peripheral Arterial Disease Risk: The Women's Health Initiative." Am Heart J 2006;152:170-176.
    39. Hsia J, Manson JE, Pettinger M, Choe JG, Langer RD, Limacher M, Oberman A, Ockene J, O'Sullivan MJ, Robinson J. “Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial." PLoS Clinical Trials 2006;1(5): {Epub ahead of print].
    40. Hsia J, Otvos JD, Rossouw JE, Wu L, Wassertheil-Smoller S, Hendrix SL, Robinson JG, Lund B, Kuller LH, for the Women's Health Initiative Research Group. “Lipoprotein Particle Concentrations May Explain the Absence of Coronary Protection in the Women's Health Initiative Hormone Trials.” Arterioscler Thromb Vasc Biol Sep 2008;28(9):1666-1671.
    41. Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SAA, Ko MG, Naughton MJ, Satterfield S, Bassford T. “Effects of Conjugated Equine Estrogen on Risk of Fractures, and BMD in Postmenopausal Women with Hysterectomy: Results from the Women's Health Initiative Randomized Trial." JBMR 2006;21:817-828.
    42. Jackson RD, Shidham S. “The Role of Hormone Therapy and Calcium plus Vitamin D for Reduction of Bone Loss and Risk For Fractures: Lessons Learned from the Women's Health Initiative.” Curr Osteoporos Rep 2007 Dec;5(4):153-9.
    43. Johnson SR. “The Women's Health Initiative and Hormone Therapy, 5 Years Later.” Cleve Clin J Med 2007 Oct;74(10):755-6.
    44. Kadish, Greenland P, Limacher M, Frishman, Daugherty, Parker, Schwartz. “Hormone Replacement Therapy and the QT Interval." Ann of Noninvasive Electrocardiology Oct 2004;9(4):366-374.
    45. Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Want H, Silva M, Kennedy J, rossouw J, Jackson R, Hsia J, chlebowski R, Manson J, Hanash S. "Application of Serum Proteomics to the Women's Health Initiative Conjugated Equine Estrogens Trial Reveals a Multitude of Effects Relevant to Clinical Findings." Genome Med 2009 Apr 29;1(4):47. [Epub ahead of print].
    46. Kooperberg C, Cushman M, Hsia J, Robinson J, Aragaki A, Lynch J, Baird A, Johnson K, Kuller L, Beresford S, Rodriguez B. “Can Biomarkers Identify Women at Increased Stroke Risk? The Women's Health Initiative Hormone Trials." PLoS Clin Trials 2007;2(6): e28. doi:10.1371/journal.pctr.0020028[Epub ahead of print].
    47. Kuller, LH. “Hormone Replacement Therapy and Risk of Cardiovascular Disease." Arterioscler Thromb Vasc Biol 2003;23:11-16.
    48. LaCroix AZ, Chlebowski RT, Manson JE, et al. “Health Outcomes after Stopping Conjugated Equine Estrogens among Postmenopausal Women with Prior Hysterectomy.” JAMA 2011;305(13):1305-1314.
    49. Langer RD, Pradhan AD, Lewis CE, Manson JE, Rossouw JE, Hendrix SL, LaCroix AZ, Ridker PM. “Baseline Associations Between Postmenopausal Hormone Therapy and Inflammatory, Haemostatic, and Lipid Biomarkers of Coronary Heart Disease: The Women's Health Initiative Observational Study." Thromb Haemost 2005;93:1108-1116.
    50. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M. “Estrogen plus Progestin and the Risk of Coronary Heart Disease." N Engl J Med 2003;349:523-34.
    51. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML, for the WHI and WHI-CACS Investigators. “Estrogen Therapy and Coronary-Artery Calcification." NEJM 2007;356:2591-2602.
    52. Manson JE, Bassuk SS. “Hot flashes and Hormones.” Newsweek 2007 Jan 15;149(3):56-7.
    53. Manson JE, Bassuk SS. “Invited Commentary: Hormone Therapy and Risk of Coronary Heart Disease - Why Renew the Focus on the Early Years of Menopause?” Am J Epidemiol 2007 Sep 1;166(5):511-7. Epub 2007 Jul 23.
    54. Manson JE & Bassuk SS. “Menopausal Hormone Therapy and the Risk of Coronary Heart Disease. Does the Relation Vary by Age or Time Since Menopause? The Investigator’s Perspective.” The Monitor 2007 Oct:17-22.
    55. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV. “Effect of Oestrogen plus Progestin on the Incidence of Diabetes in Postmenopausal Women: Results from the Women's Health Initiative Hormone Trial." Diabetologia 2004;47(7) :1175-1187.
    56. McGowan JA, Stefanick ML. “Estrogen Therapy: Prevention and Treatment of Osteoporosis.” In: Marcus R et al, eds. Osteoporosis 3rd ed. San Diego, CA: Elsevier Academic Press,2008:1687-704.
    57. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS. “Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized Trial." J Natl Cancer Inst 2005;97:1366-76.
    58. Modugno F, Kip KE, Cochrane B, Kuller L, Klug TL, Rohan TE, Chlebowski RT, Lasser N, Stefanick ML. “Obesity, Hormone Therapy, Estrogen Metabolism and Risk of Postmenopausal Breast Cancer." Int J Cancer 2006;118:1292-1301.
    59. Ness RB, Albano JD, McTiernan A, Cauley JA. “Influence of Estrogen Plus Testosterone Supplementation on Breast Cancer.” Arch Intern Med 2009;169(1):41-46.
    60. Ockene JK, Barad DH, Cochrane BB, Larson JC, Gass M, Wassertheil-Smoller S, Manson JE, Barnabei VM, Lane DS, Brzyski RG, Rosal MC, Wylie-Rosett J, Hays J. “Symptom Experience After Discontinuing Use of Estrogen Plus Progestin." JAMA 2005;294:183-193.
    61. Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S, Barnabei VM, Wassertheil-Smoller S. “Association of Pelvic Organ Prolapse and Fractures in Postmenopausal Women: Analysis of Baseline Data from the Women's Health Initiative Estrogen Plus Progestin Trial." Menopause 2008;15(1):59-66.
    62. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. “Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease: Prospective Analysis From the Women's Health Initiative Observational Study." JAMA 2002;288:980-987.
    63. Prentice RL. “Postmenopausal Hormone Therapy in Relation to Cardiovascular Disease and Cognition." Proceedings of the Forty Seventh Study Group of the Royal College of Obstetricians and Gynecologists, 2004.
    64. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. “Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial." Am J Epidemiol 2005;162:1-11.
    65. Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. “Combined Analysis of Women's Health Initiative Observational and Clinical Trial Data on Postmenopausal Hormone Treatment and Cardiovascular Disease." Am j Epidemiol 2006;163(7):589-599.
    66. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O’Sullivan JM, Rossouw JE, Anderson GL. “Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women.” Am J Epidemiol May 2008;167:1207-1216.
    67. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O’Sullivan MJ, Rossouw JE, Anderson GL. “Conjugated Equine Estrogens and Breast Cancer Risk in the Women’s Health Initiative Clinical Trial and Observational Study.” Am J Epidemiol June 2008;167(12):1407-15.
    68. Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT. “Conjugated Equine Estrogens and Colorectal Cancer Incidence and Survival: The Women’s Health Initiative Randomized Clinical Trial.” Cancer Epidemiol Biomarkers Prev 2008;17(10):2609-2618.
    69. Resnick SM, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, Ockene J, Davatzikos C. “Postmenopausal Hormone Therapy and Regional Brain Volumes: The WHIMS-MRI Study." Neurology 2009;72(2):135-142.
    70. Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M, Wassertheil-Smoller S, Page DL. “Conjugated Equine Estrogen and Risk of Benign Proliferative Breast Disease: A Randomized Controlled Trial.” J Natl Cancer Inst Apr 2008;100:563-571.
    71. Rohan TE, Negassa A, Chlebowski RT, Lasser NL, McTiernan A, Schenken RS, Ginsberg M, Wassertheil-Smoller S, Page DL. “Estrogen Plus Progestin and Risk of Benign Proliferative Breast Disease.” Cancer Epidemiol Biomarkers Prev Sep 2008;17(9):2337-2343.
    72. Rossouw JE. “Estrogens for Prevention of Coronary Heart Disease: Putting the Breaks on the Bandwagon." Circulation 1996;94:2982-2985.
    73. Rossouw JE. “Implications of Recent Clinical Trials of Postmenopausal Hormone Therapy for Management of Cardiovascular Disease.” Ann N Y Acad Sci 2006 Nov;1089:444-53.
    74. Rossouw, JE, Prentice RL, Manson JE, Wu LL, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. “Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause." JAMA 2007;297:1465-1477.
    75. Rossouw JE. “Postmenopausal Hormone Therapy for Disease Prevention: Have We Learned Any Lessons from the Past?” Clin Pharmacol Ther 2008 Jan;83(1):14-6.
    76. Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, Pettinger M, Robinson J, Hendrix S, Hsia J. “Inflammatory, Lipid, Thrombotic, and Genetic Markers of Coronary Heart Disease Risk in the Women’s Health Initiative Trials of Hormone Therapy.” Arch Intern Med 2008 Nov 10;168(20):2245-53.
    77. Rossouw J, Bray P, Liu J, Kooperberg C, Hsia J, Lewis C, Cushman M, Bonds D, Hendrix S, Papanicolaou G, Howard T, Herrington D. “Estrogen Receptor Polymorphisms and the Vascular Effects of Hormone Therapy." Arterioscler Thromb Vasc Biol. 2010 Nov 24. [Epub ahead of print].
    78. Shih RA, Griffin BA, Salkowski N, Jewell A, Eibner C, Bird CE, Liao D, Cushman M, Margolis HG, Eaton CB, and Whitsel EA. “Ambient Particulate Matter Air Pollution and Venous Thromboembolism in the Women’s Health Initiative Hormone Therapy Trials." Environ Health Perspect. 29 Oct 2010. [Epub ahead of print].
    79. Stefanick M, Cochrane B, Hsia J, Barad D, Liu J, Johnson S. “The WHI Postmenopausal Hormone Trials." Ann Epidemiol 2003;13:S78-S86.
    80. Stefanick ML, Prentice RL, Anderson G, Gass M, Manson JE, Hendrix SL, Vista-Deck D, McNeeley G. “Reanalysis of the Women's Health Initiative Oral Contraceptive Data Reveals No Evidence of Delayed Cardiovascular Benefit." Fertility and Sterility April 2005;83(4):853-854.
    81. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT. “Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With Hysterectomy." JAMA 2006;295(14):1647-1657.
    82. Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC, Howard BV, for the Women’s Health Initiative Investigators. “Effects of Postmenopausal Hormone Therapy on Rheumatoid Arthritis: The Women’s Health Initiative Randomized Controlled Trials.” Arthritis & Rheumatism Mar 2008;59(3):302-310.
    83. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ. “Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial." JAMA 2003;289:2673-2684.
    84. Wassertheil-Smoller S, Kooperberg C, McGinn AP, Kaplan RC, Hsia J, Hendrix SL, Manson JE, Berger JS, Kuller LH, Allison MA, Baird AE. “Lipoprotein-Associated Phospholipase A2, Hormone Use, and the Risk of Ischemic Stroke in Postmenopausal Women." Hypertension 2008;51:1-8.
    85. Willett WC, Manson JE, Grodstein F, Stampfer MJ, Colditz GA. “Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy Between Observational Studies and the Women's Health Initiative Clinical Trial.” Am J Epidemiol 2006 Jun 1;163(11):1067-8.
    86. Women's Health Initiative Steering Committee. “Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women's Health Initiative Randomized Controlled Trial." JAMA 2004;291(14):1701-1712.
    87. Writing Group for the Women's Health Initiative Investigators. “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women." JAMA 2002;288:321-333.
    88. Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W; Women's Health Initiative Investigators. “Effects of Estrogen With and Without Progestin and Obesity on Symptomatic Gastroesophageal Reflux.” Gastroenterology 2008 Jul;135(1):72-81.

    Other

    1. Abel EL, Hendrix SO, McNeeley SG, Johnson KC, Rosenberg CA, Mossavar-Rahmani Y, Vitolins M, Kruger M. “Daily Coffee Consumption and Prevalence of Nonmelanoma Skin Cancer in Caucasian Women." Eur J Cancer Prev 2007 Oct;16(5):446-452.
    2. Assaf A, Carleton R, Miller M, Coccio E. “Estimating Normal Hemogram Values for Postmenopausal Women." Clinical Journal of Women's Health 2000;1(1):23-28.
    3. Avery CL, Mills KT, McGraw K, Smith RL, Poole C, Whitsel EA. "Estimating Error in Using Ambient PM2.5 Concentrations as Proxies for Personal Exposures: A Meta-analysis." Epidemiology 2008;19(6):S186.
    4. Baker MW, LaCroix AZ, Wu C, Cochrane BB, Wallace R, Woods NF. “Mortality Risk Associated with Physical and Verbal Abuse in Women Aged 50 to 79."J Am Geriatr Soc. 2009 Aug 13. [Epub ahead of print]
    5. Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB. “Prior Oral Contraception and Postmenopausal Fracture: Awomen's Health Initiative Observational Cohort Study." Fertil Steril 2005;84(2):374-384.
    6. Barad DH, Stefanick ML, Manson JE, Gass M, Anderson GL. Reply: “Reanalysis of the Data--Science at its Best and Always Informative.” Fertil Steril 2006 June;85(6): author reply e14.
    7. Brennan RM, Genco RJ, Wilding GE, Hovey KM, Trevisan M, Wactawski-Wende J. “Bacterial Species in Subgingival Plaque and Oral Bone Loss in Postmenopausal Women." J Periodontol 2007;78(6):1051-1061.
    8. Brennan RM, Genco RJ, Hovey KM, Trevisan M, Wactawski-Wende J. “Clinical Attachment Loss, Systemic Bone Density, and Subgingival Calculus in Postmenopausal Women.” J Periodontol 2007 Nov;78(11):2104-11.
    9. Bush TM, Bonomi AE, Nekhlyudov L, Ludman EJ, Reed SD, Connelly MT, Grothaus LC, LaCroix AZ, Newton KM. “How the Women's Health Initiative (WHI) Influenced Physicians' Practice and Attitudes.” J Gen Intern Med 2007 Sep;22(9):1311-6.
    10. Chan KH, Brennan K, You NC, Lu X, Song Y, Hsu YH, Chaudhuri G, Nathan L, Tinker L, and Liu S. “Common Variations in the Genes Encoding C-Reactive Protein, Tumor Necrosis Factor, and Interleukin-6, and the Risk of Clinical Diabetes in the Women’s Health Initiative Observational Study." Clin Chem. 2010 Dec 13. [Epub ahead of print].
    11. Chen JC, Brunner RL, Ren H, Wassertheil-Smoller S, Larson JC, Levine DW, Allison M, Naughton MJ, Stefanick ML. “Sleep Duration and Risk of Ischemic Stroke in Postmenopausal Women.” Stroke Dec 2008;39:3185-3192.
    12. Crooks JL, Whitsel EA, Quibrera PM, Catellier DJ, Liao D, Smith RL. "the Effect of Ignoring Interpolation Error on the Inferred Relationship Between Ambient Particulate Matter Exposure and Median RR Interval in Post-Menopausal Women." Epidemiology 2008;19(6):S127.
    13. Fox ER, Young JH, Li Y, et al. “Association of Genetic Variation with Systolic and Diastolic Blood Pressure among African Americans: The Candidate Gene Association Resource (CARe) Study.” Hum Mol Genet. 2011 Apr 1. [Epub ahead of print].
    14. Gold R, Michael YL, Whitlock EP, Hubbell FA, Mason ED, Rodriguez BL, Safford MM, Sarto GE. “Race/ethnicity, Socioeconomic Status, and Lifetime Morbidity Burden in the Women's Health Initiative: A Cross-Sectional Analysis.” J Womens Health (Larchmt) 2006 Dec;15(10):1161-73.
    15. Gray SL, LaCroix AZ, Aragaki AK, McDermott M, Cochrane BB, Kooperberg CL, Murray AM, Rodriguez B, Black H, Woods NF; Women's Health Initiative Observational Study. “Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty in Women Aged 65 and Older: Prospective Findings from the Women's Health Initiative Observational Study." J Am Geriatr Soc 2009 Feb;57(2):297-303.
    16. Hall WD, Pettinger M, Oberman A, Watts NB, Johnson KC, Paskett ED, Limacher MC, Hayes J. “Risk Factors for Kidney Stones in Older Women in the Southern United States." Am J Med Sci 2001;322(1):1-7
    17. Howard BV. “The Women's Health Initiative: A Potential Resource for Future Studies ofAutoimmune Diseases." Autoimmunity 2004;37(4):265-268.
    18. Howard BV, Adams-Campbell L, Allen C, Black H, Passaro M, Rodabough RJ, Rodriguez BL, Safford M, Stevens VJ, Wagenknecht LE. “Insulin Resistance and Weight Gain in Postmenopausal Women of Diverse Ethnic Groups." International J Obesity Aug 2004;28:1039-1047.
    19. Hsu Y, Niu T, Song Y, Tinker L, Kuller LH, Liu S. “Genetic Variants in the UCP2-UCP3 Gene Cluster and Risk of Diabetes Mellitus in the Women's Health Initiative Observational Study." Diabetes Epub 2008 Jan 25.
    20. Jackson M, Berman N, Huber M, Snetselaar L, Granek I, Boe K, Milas C, Spivak J, Chlebowski RT. “Research Staff Turnover and Participant Adherence in the Women's Health Initiative." Controlled Clinical Trials 2003;24:422-435.
    21. Jaramillo SA, Felton D, Andrews LA, Desiderio L, Hallarn RK, Jackson SD, Coker LH, Robinson JG, Ockene JK, Espeland MA, for the Women's Health Initiative Memory Study Research Group. “Enrollment in a Brain Magnetic Resonance Study: Results From the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI)" Acad Radiol 2007;14(5):603-612.
    22. LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Newman AB, Kooperberg CL, Black H, Curb JD, Greenland P, Woods NF. “Statin Use and Incident Frailty in Women Aged 65 Years or Older: Prospective Findings From the Women's Health Initiative Observational Study.” J Gerontol A Biol Sci Med Sci Apr 2008;63(4):369-75.
    23. Langer R, White E, Lewis C, Kotchen J, Hendrix S, Trevisan M. “The WHI Observational Study: Baseline Characteristics of Participants and Reliability of Baseline Measures." Ann Epidemiol 2003;13:S107-S121.
    24. LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R; CAREDS Macular Pigment Study Group. “Macular Pigment Density and Age-Related Maculopathy in the Carotenoids in Age-Related Eye Disease Study: An Ancillary Study of the Women’s Health Initiative.” Ophthalmology 2008 May;115(5):876-883.
    25. Lederle FA, Larson JC, Margolis KL, Allison MA, Freiberg MS, Cochrane BB, Graettinger WF, Curb JD, Women’s Health Initiative Cohort Study. “Abdominal Aortic Aneurysm Events in the Women’s Health Initiative: Cohort Study.” BMJ 2008 Oct 14. [Epub ahead of print].
    26. Lee CC, You NY, Sont Y, Hsu Y, Manson J, Nathan L, Tinker L, Liu S. "Relation of Genetic Variation in the Gene Coding for C-Reactive Protein with its Plasma Protein Concentrations: Findings from the Women's Health Initiative Observational Cohort." Clin Chem 2008 Dec 18. [Eput ahead of print].
    27. Liao D, Whitsel EA, Duan Y, Lin HM, Quibrera PM, Smith R, Peuquet DJ, Prineas RJ, Zhang ZM, Anderson G. “Ambient Particulate Air Pollution and Ectopy: The environmental Epidemiology of Arrhythmogenesis in Women’s Health Initiative Study, 1999-2004.” J Toxicol Environ Health A 2009;72(1):30-38.
    28. Liao D, Peuquet DJ, Duan Y, Whitsel EA, Dou J, Smith RL, Lin HM, Chen JC, Heiss G. “GIS Approaches for the Estimation of Residential-Level Ambient PM Concentrations.” Environ Health Perspect 2006 Sep;114(9):1374-80.
    29. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, Heiss G, Howard BV, Hotamisligil GS, Hu FB, Kuller LH, Manson JE. “A prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women." Arch Intern Med 2007;167(15):1676-1685.
    30. Mares JA, Voland RP, Sondel SA, Millen AE, LaRowe T, Moeller SM, Klein ML, Blodi BA, Chappell RJ, Tinker L, Ritenbaugh C, Gehrs KM, Sarto GE, Johnson E, Snodderly DM, and Wallace RB. “Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration." Arch Ophthalmol. 2010 Dec 13. [Epub ahead of print].
    31. Moeller SM, Parekh N, Tinker L, Ritenbaugh C, Blodi B, Wallace RB, Mares JA, CAREDS Research Study Group. “Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS): Ancillary Study of the Women's Health Initiative.” Arch Ophthalmol 2006 Aug;124(8):1151-62.
    32. Mares JA, LaRowe TL, Snodderly DM, Moeller SM, Gruber MJ, Klein ML, Wooten BR, Johnson EJ, Chappell RJ; CAREDS Macular Pigment Study Group and Investigators. “Predictors of Optical Density of Lutein and Zeaxanthin in Retinas of Older Women in the Carotenoids in Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative.” Am J Clin Nutr 2006 Nov;84(5):1107-22.
    33. Mares JA, Voland RP, Sondel SA, Millen AE, LaRowe T, Moeller SM, Klein ML, Blodi BA, Chappell RJ, Tinker L, Ritenbaugh C, Gehrs KM, Sarto GE, Johnson E, Snodderly DM, and Wallace RB. “Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration." Arch Ophthalmol. 2010 Dec 13. [Epub ahead of print].
    34. Margolis KL, Qi L, Brzyski R, Bonds DE, Howard BV, Kempainen S, Liu S, Robinson JG, Safford MM, Tinker LT, Phillips LS. “Validity of Diabetes Self-Reports in the Women’s Health Initiative: Comparison with Medication Inventories and Fasting Glucose Measurements.” Clinical Trials 2008;5(3):240-247.
    35. McCall-Hosenfeld JS, Jaramillo SA, Legault C, Freund KM, Cochrane BB, Manson JE, Wenger NK, Eaton CB, Rodriguez BL, McNeeley SG, Bonds D. “Correlates of Sexual Satisfaction Among Sexually Active Postmenopausal Women in the Women’s Health Initiative Observational Study.” J Gen Intern Med 2008 Oct 7. [Epub ahead of print]
    36. McGinn AP, Kaplan RC, Verghese J, Rosenbaum DM, Psaty BM, Baird AE, Lynch JK, Wolf PA, Kooperberg C, Larson JC, Wassertheil-Smoller S. “Walking Speed and Risk of Incident Ischemic Stroke Among Postmenopausal Women." Stroke 2008 Feb 21 [Epub ahead of print].
    37. McTiernan A, Wu L, Barnabei VM, Chen C, Hendrix S, Modugno f, Rohan T, Stanczyk FZ, Wang CY, for the Women's Health Initiative Investigators. “Relation of Demographic Factors, Menstrual History, Reproduction and Medication Use to Sex Hormone Levels in Postmenopausal Women." Breast Cancer Res Treat 2008;108(2):217-231.
    38. Meyer AM, Evenson KR, Moritoto L, Siscovick D, White E. “Test-Retest Reliability of the Women's Health Initiative Physical Activity Questionnaire." Med Sci Sports Exerc 2009 Feb 6. [Epub ahead of print]
    39. Moeller SM, Voland R, Tinker L, Blodi BA, Klein ML, Gehrs KM, Johnson EJ, Snodderly M, Wallace RB, Chappell RJ, Parekh N, Ritenbaugh C, Mares JA; CAREDS Study Group. “Associations Between Age-Related Nuclear Cataract and Lutein and Zeaxanthin in the Diet and Serum in the Carotenoids in the Age-Related Eye Disease Study (CAREDS), an Ancillary Study of the Women’s Health Initiative.” Arch Ophthalmol Mar 2008;126(3):354-364.
    40. Mouton CP, Rovi S, Furniss K, Lasser NL. “The Associations Between Health and Domestic Violence in Older Women: Results of a Pilot Study." Journal of Women's Health and Gender-Based Medicine 1999;6(9):1173-1179.
    41. Mouton C, Rodabough R, Robi S, Hunt J, Talamantes M, Brzyski R, Burge S. “Prevalence and 3-Year Incidence of Abuse Among Postmenopausal Women." Am J of Public Health 2004;94:605-612.
    42. Nabel EG. “The Women's Health Initiative.” Science 2006 Sep 22;313(5794):1703.
    43. Pradhan AD, Manson JE, Hendrix SL, Johnson KC, Waenknecht LE, Haan MN, Weidner G, LaCroix AZ, Cook NR. “Cross-Sectional Correlates of Fasting Hyperinsulinaemia in Post-Menopausal Women of Different Ethnic Origin." Diabet Med 2006;23:77-85.
    44. Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, Cushman M, Rohan TE, McGinn AP, Wang T, Strickler HD, Scherer PE, Mackey R, Curb D, Ho GY. “Resistin, but not Adiponectin and Leptin, is Associated with the Risk of Ischemic Stroke among Postmenopausal Women.” Stroke. 2011 May 5. [Epub ahead of print].
    45. Reiner AP, Aragaki AK, Gray SL, Wactawski-Wende J, Cauley JA, Cochrane BB, Kooperberg CL, Woods NF, LaCroix AZ. “Inflammation and Thrombosis Biomarkers and Incident Frailty in Postmenopausal Women." Am J Med 2009;122(10):947-54.
    46. Robinson JG, Manson JE, Larson J, Liu S, Song Y, Howard BV, Phillips L, Shikany JM, Allison M, Curb JD, Johnson KC, Watts N. ”Lack of Association Between 25(OH)D Levels and Incident Type 2 Diabetes in Older Women.” Diabetes Care. 2011 Feb 2. [Epub ahead of print].
    47. Rosso AL, Eaton CB, Wallace R, Gold R, Curb JD, Stefanick ML, Ockene JK and Michael YL. ”Combined Impact of Geriatric Syndromes and Cardiometabolic Diseases on Measures of Functional Impairment.” J Gerontol A Biol Sci Med Sci. 2011 Feb 11. [Epub ahead of print].
    48. Shikany JM, Patterson RE, Agurs-Collins T, Anderson G. “Antioxidant Supplement Use in Women's Health Initiative Participants." Preventive Medicine 2003;36:379-387.
    49. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB, Hotamisligil GS, Ridker PM, Rodriguez BL, Margolis KL, Oberman A, Liu S. “Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.” Diabetes 2007 Jul;56(7):1898-904.
    50. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S. “Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: The Women's Health Initiative Observational Study.” Diabetes Care 2007 Jul;30(7):1747-52.
    51. Song Y, You NC, Hsu YH, Sul J, Wang L, Tinker L, Eaton CB, Liu S. “Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women.” Hum Mol Genet 2007 Dec 1;16(23):2960-71.
    52. Song Y, You N, Hsu Y, Howard BV, Langer RD, Manson JE, Nathan L, Niu T, Tinker LF, Liu S. “FTO Polymorphisms Are Associated With Obesity but Not Diabetes Risk in Postmenopausal Women.” Obesity 2008;16:2472-2480.
    53. Valanis BG, Bowen DJ, Bassford T, Whitlock E, Charney P, Carter RA. “Sexual Orientation and Health: Comparisons in the Women's Health Initiative Sample." Archives of Family Medicine. Sept-Oct 2000;9(9):843-53.
    54. Van Horn L, Manson JE. “The Women’s Health Initiative: Implications for clinicians.” Cleve Clin J Med 2008 May;75(5):385-90.
    55. Walitt BT, Constantinescu F, Katz JD, Weinstein A, Wang H, Hernandez RK, Hsia J, Howard BV. “Validation of Self-Report of Rheumatoid Arthritis and Systemic Lupus Erythematosus: The Women's Health Initiative.” J Rheumatol 2008;35(5):811-818.
    56. Wang T, Ho G, Ye K, Strickler H. Elston RC. “A Partial Least-Square Approach for Modeling Gene-Gene and Gene-Environment Interactions When Multiple Markers are Genotyped.” Genet Epidemiol Jul 2008. [Epub ahead of print]
    57. White E, Kristal A, Shikany J, Wilson A, Chen C, Mares-Perlman J, Masaki K, Caan B. “Correlates of Serum Alpha- and Gamma-Tocopherol in the Women's Health Initiative." Annals of Epidemiology 2001;11:136-144.
    58. Whitsel EA, Quibrera PM, Smith RL, Catellier DJ, Liao D, Henley AC, Heiss G. “Accuracy of Commercial Geocoding: Assessment and Implications.” Epidemiol Perspect Innov 2006 Jul 20;3:8.
    59. Whitsel EA, Quibrera PM, Christ SL, Liao D, Prineas RJ, Anderson GL, Heiss G. "Heart Rate Variability, Ambient Particulate Matter Air Pollution, and Glucose Hemeostatis: the Environmental Epidemiology of Arrhythmogenesis in the Women's Health Initiative." Am J Epidemiol 2009 [Epub ahead of print].
    60. Wildman RP, Kaplan R, Manson JE, Rajkovic A, Connelly SA, Mackey RH, Tinker LF, Curb JD, Eaton CB and Wassertheil-Smoller S. ”Body Size Phenotypes and Inflammation in the Women’s Health Initiative Observational Study.” Obesity. 2011 Jan 13. [Epub ahead of print].
    61. Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murry A, Newman AB. “Frailty: Emergence and Consequences in Women Aged 65 and Older in the Women's Health Initiative Observational Study." J Am Geriatr Soc 2005;53:1321-1330.
    62. Wright NC, Riggs GK, Lisse JR, Chen Z. “Self-Reported Osteoarthritis, Ethnicity, Body Mass Index, and Other Associated Risk Factors in Postmenopausal Women: Results From the Women's Health Initiative.” J Am Geriatr Soc 2008 Sep;56(9):1736-43.
    63. Wylie-Rosetta J, Aragaki AK, Cochrane B, Perri MG, Rosal MC and Rapp SR. “Cynicism: Incident Diabetes and Worsening of Metabolic Syndrome in Postmenopausal Women.” Diabetes Metab Syndr: Clin Res & Rev. 2010 Oct-Dec;(4):187–189.
    64. Zhang ZM, Whitsel EA, Quibrera PM, Smith RL, Liao D, Anderson GL, Prineas RJ. "Ambient Fine Particulate Matter Exposure and Myocardial ischemia in the Environmental Epidemiology of Arrhythmogenesis in the Women's Health Initiative (EEAWHI)." Environ Health Perspect 2009 [Epub ahead of print].
    65. Zhu X, Young JH, Fox E, et al. “Combined Admixture Mapping and Association Analysis Identifies a Novel Blood Pressure Genetic locus on 5p13 : Contributions from the CARe Consortium.” Hum Mol Genet. 2011 Mar 21. [Epub ahead of print].

    Pelvic Prolapse and Urinary Incontinence

    1. Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. “Natural History of Pelvic Organ Prolapse in Postmenopausal Women.” Obstet Gynecol 2007 Apr;109(4):848-54.
    2. Bradley CS, Zimmerman MB, Wang Q, Nygaard IE, for the Women’s Health Initiative. “Vaginal Descent and Pelvic Floor Symptoms in Postmenopausal Women: A Longitudinal Study.” Obstet Gynecol May 2008;111(5):1148-1153.
    3. Handa VL, Garret E, Hendrix S, Gold E, Robbins J. “Progression and Remission of Pelvic Organ Prolapse: A Longitudinal Study of Menopausal Women." Am J Obstetrics and Gynecology 2004;190:27-32.
    4. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. “Pelvic Organ Prolapse in the Women's Health Initiative: Gravity and Gravidity." Am J Obstet Gynecol 2002;186:1160-1166.
    5. Kudish BI, Iglesia CB, Sokol RJ, Cochrane B, Richter HE, Larson J, Hendrix SL, Howard BV. "Effect of Weight Change on Natural History of Pelvic Organ Prolapse." Obstet Gynecol 2009 Jan;113(1):81-88.
    6. Nygaard I, Bradley C, Brandt D. “Pelvic Organ Prolapse in Older Women: Prevalence and Risk Factors." Obstetrics and Gynecology 2004;104(3):489-497.
    7. Pastore LM, Carter RA, Hulka BS, Wells E. “Self-Reported Urogenital Symptoms in Postmenopausal Women: Women's Health Initiative." Maturitas 2004;49:292-303.

     

    		•
     
     
    Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute

    Please send us your feedback, comments, and questions
    by using the appropriate link on the page, Contact the NHLBI.

    Note to users of screen readers and other assistive technologies: please report your problems here.
    Link to DHHS Link to NIH Link to NHLBI Link to DHHS Link to WHI Home